Adrenal cortical hormones




Adenosine 3′-phosphate


Adenosine 5′-phosphate

Cyclic AMP

Adenosine 3′, 5′-phosphate


Free fatty acids


Immunoreactive glucagon


TPNH=Nicotinamide-adenine dinucleotide phosphate


Pyruvate carboxylase


Phosphoenolpyruvate carboxykinase




Uridine diphosphoglucose


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe, M., and S. Ikawa: Glucagon and carbohydrate metabolism. Folia endocr. jap. 38, 560 (1962).PubMedGoogle Scholar
  2. 2.
    — S. Nakano, T. Tanese, S. Asano, Y. Sugiura, and Y. Ikeda: Interrelation between insulin and glucagon under physiologic conditions. Jikeikai med. J. 11, 229 (1965).Google Scholar
  3. 3.
    Y. Sogiura, and Y. Ikeda: Diabetogenic activity of glucagon. 5th Congr. Intern. Diabetes Federation, Toronto, July 1964.Google Scholar
  4. 4.
    Abraham, S., B. Borrebaek, and I. L. Chaikoff: Effect of dietary carbohydrate on glucokinase and mannokinase activities of various rat tissues. J. Nutr. 83, 273 (1964).PubMedGoogle Scholar
  5. 5.
    Abramson, E. A., R. A. Arky, and K. A. Woeber: Effect of beta-adrenergic blockade on growth hormone and catecholamine counter-regulation in acute hypoglycemia. Clin. Res. 14, 476 (1966).Google Scholar
  6. 6.
    Agid, R., R. Duguy et H. St. Girons: Variations de la glycémie, du glacogène hépatique et de l’aspect histologique du pancréas chez Vipera aspis au cours du cycle annuel. J. Physiol. (Paris) 53, 807 (1961).Google Scholar
  7. 7.
    Allen, D. T., D. Kornhauser, and R. Schwartz: Glucose homeostasis in the newborn puppy. Amer. J. Dis. Child. 112, 343 (1966).PubMedGoogle Scholar
  8. 8.
    Alm, G., and B. Hellman: Distribution of the two types of A cells in the pancreatic islets of some mammalian species. Acta endocr. (Kbh.) 46, 307 (1964).PubMedGoogle Scholar
  9. 9.
    Amatuzio, D. S., F. Grande, and S. Wada: Effect of glucagon on the serum lipids in essential hyperlipemia and in hypercholesterolemia. Metabolism 11, 1240 (1962).PubMedGoogle Scholar
  10. 10.
    Anderson, J., and G. Hollifield: Glucose-6-phosphate dehydrogenase activity in adipose tissue from two types of obese mice during starvation. Metabolism 15, 1092 (1966).PubMedGoogle Scholar
  11. 11.
    Angervall, L., C. Hellerström, and B. Hellman: Development of the endocrine pancreas of rats as manifested by the appearance of argyrophilia and granulation. Path. et Microbiol. (Basel) 25, 389 (1962).Google Scholar
  12. 12.
    Appleman, M. M., L. Birmbaumer, and H. N. Torres: Factors affecting the activity of muscle glycogen synthetase. III. The reaction with adenosine triphosphate, Mg++, and cyclic 3′5′-adenosine monophosphate. Arch. Biochem. 116, 39 (1966).PubMedGoogle Scholar
  13. 13.
    — E. G. Krebs, and E. H. Fischer: Purification and properties of inactive liver phosphorylase. Biochemistry 5, 2101 (1966).PubMedGoogle Scholar
  14. 14.
    Assan, R., G. Rosselin, J. Drouet, J. Dolais, and G. Tchobroutsky: Glucagon antibodies. Lancet 1965 II, 590.Google Scholar
  15. 15.
    — — — — —et M. Derot: Dosage radioimmunologique du glucagon plasmatique chez l’homme. Résultats préliminaires. Ann. Endocr. (Paris) 27, 690 (1966).PubMedGoogle Scholar
  16. 16.
    — — G. Tschobroutsky, J. Dolais, and P. Freychet: Effect of various preparations of glucagon, insulin, secretin, pancreozymin, digestive mucosae and pancreatic extracts on binding of radio-iodinated glucagon by anti-glucagon antisera. Sixth Congr. Intern. Diabetes Feder., Excerpta Med., I. C. S. No 140, 113 (1967).Google Scholar
  17. 17.
    Assimacopoulos, C. A., W. F. Prigge, W. R. Anderson, and F. Grande: Effects of pancreatectomy and of CoCl2 in the duck. Fed. Proc. 25, 442 (1966).Google Scholar
  18. 18.
    Aylett, P.: The effects of glucagon and glucagon-free insulin upon gastric secretion in peptic ulcer patients. Clin. Sci. 22, 179 (1963).Google Scholar
  19. 19.
    Azerad, E., J. Lubetzki et J. Duprey: Antagonistes et inhibiteurs de l’insuline. Ann. Endocr. (Paris) 27, 608 (1966).PubMedGoogle Scholar
  20. 20.
    Bader, J. P., F. G. Potet et A. Lambling: Étude histologique des îlots de Langerhans non tumoraux dans le syndrome de Zollinger-Ellison. Gastroenterologia (Basel) 102, 135 (1964).PubMedGoogle Scholar
  21. 21.
    Ball, E. G., and R. L. Jungas: Studies on the metabolism of adipose tissue. XIII. The effect of anaerobic conditions and dietary regime on the response to insulin and epinephrine. Biochemistry 2, 586 (1963).PubMedGoogle Scholar
  22. 22.
    Ball, E. G., and R. L. Jungas: Some effects of hormones on the metabolism of adipose tissue. Recent Progr. Hormone Res. 20, 183 (1964).PubMedGoogle Scholar
  23. 23.
    Ballard, F. J., and I. T. Oliver: Glycogen metabolism in embryonic chick and neonatal rat liver. Biochim. biophys. Acta (Amst.) 71, 578 (1963).PubMedGoogle Scholar
  24. 24.
    Bally, P. R., H. Kappeler, E. R. Froesch, and A. Labhart: Effect of glucose on spontaneous limitation of lipolysis in isolated adipose tissue; a potential regulatory mechanism. Ann. N.Y. Acad. Sci. 131, 143 (1965).PubMedGoogle Scholar
  25. 25.
    Barac, G.: Action du glucagon sur la diurèse du chien brulé. C. R. Soc. Biol. (Paris) 157, 2345 (1964).Google Scholar
  26. 26.
    Influence du glucagon sur l’excrétion urinaire du phosphore inorganique chez le chien. C. R. Soc. Biol. (Paris) 159, 1859 (1966).Google Scholar
  27. 27.
    Barrett, A. M.: The role of plasma free fatty acids in the elevation of plasma cholesterol and phospholipids produced by adrenaline. J. Endocr. 36, 301 (1966).PubMedGoogle Scholar
  28. 28.
    Barrington, E. J. W.: An introduction to general and comparative endocrinology. Oxford: Clarendon Press 1963.Google Scholar
  29. 29.
    Baum, J., B. E. Simons, R. H. Unger, and L. L. Madison: Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent technics. Diabetes 11, 371 (1962).PubMedGoogle Scholar
  30. 30.
    Beatty, C. H., C. H. Peterson, R. M. Bocek, N. C. Craig, and R. Weleber: Effect of glucagon on incorporation of glycine-C14 into protein of valuntary skeletal muscle. Endocrinology 73, 721 (1963).PubMedGoogle Scholar
  31. 31.
    Beekman, B. E.: The hormonal regulation of blood glucose concentration in the fowl with special emphasis on the role of glucagon. Thesis Indiana University 1965. University Microfilms No 66-1423.Google Scholar
  32. 32.
    Bencosme, S. A., J. Meyer, B. J. Bergman, and A. Martinez-Palomo: The principal islet of bullhead fish (Ictalurus nebulosus). Rev. canad. Biol. 24, 141 (1965).PubMedGoogle Scholar
  33. 33.
    Benedetti, A., and F. O. Kolb: Metabolic effects of glucagon and epinephrine in four adults with type I glycogen storage disease. Diabetes 15, 529 (1966).Google Scholar
  34. 34.
    R. G. Simpson, G. M. Grodsky, and P. H. Forsham: Serum insulin response to glucagon as an index of insulinogenic reserve. Intern. Symp. Pharmacol. Hormonal Polypept. Prot. Adv. exp. Med. Biol. 2 (in press).Google Scholar
  35. 35.
    Bentley, P. J., and B. K. Follett: The effects of hormones on the carbohydrate metabolism of the lamprey Lampetra fluviatilis. J. Endocr. 31, 127 (1965).PubMedGoogle Scholar
  36. 36.
    Bergen, S. S. jr., J. G. Hilton, and T. B. van Itallie: Glycogenolytic effect of adenosine 3′,5′-monophosphate in canine liver. Endocrinology 79, 1065 (1966).PubMedGoogle Scholar
  37. 37.
    Berger, S., J. L. Downey, H. S. Traisman, and R. Metz: Mechanism of the cortisone-modified glucose tolerance test. New Engl. J. Med. 274, 1460 (1966).PubMedGoogle Scholar
  38. 38.
    Bergström, S.: The prostaglandins. Recent Progr. Hormone Res. 22, 153 (1966).PubMedGoogle Scholar
  39. 39.
    Berson, S. A., and R. S. Yalow: Radioimmunoassays of peptide hormones in plasma. New Engl. J. Med. 277, 640 (1967).PubMedGoogle Scholar
  40. 40.
    —, and B. W. Volk: In vivo and in vitro metabolism of insulin-I131 and glucagon-I131 in normal and cortisone-treated rabbits. J. Lab. clin. Med. 49, 331 (1957).PubMedGoogle Scholar
  41. 41.
    Beskid, M.: Effect of administration of cobalt chloride on the pancreas of the guinea pig. Folia histochem. cytochem. (Cracow). 1, 95 (1963).Google Scholar
  42. 42.
    Bessman, S. P.: A molecular basis for the mechanism of insulin action. Amer. J. Med. 40, 740 (1966).PubMedGoogle Scholar
  43. 43.
    Bewsher, P. D., and J. Ashmore: Ketogenic and lipolytic effects of glucagon on liver. Biochem. biophys. Res. Commun. 24, 431 (1966).PubMedGoogle Scholar
  44. 44.
    — C. C. Hillman, and J. Ashmore: Studies on the inhibition of insulin action in vitro by beta adrenergic blocking agents. Ann. N.Y. Acad. Sci. 139, 890 (1967).Google Scholar
  45. 45.
    — M. E. Tarrant, and J. Ashmore: Effects of fat mobilization on liver acetate metabolism. Diabetes 15, 346 (1966).PubMedGoogle Scholar
  46. 46.
    Bianucci, G.: Glucagone e metabolism lipidico. 3. Modificazioni della lipemia totale, dei fosfolipidi e dei grassi neutri ematici da stimolo glucagonico. Rev. Crit. Clin. Med. 65, 523 (1965).Google Scholar
  47. 47.
    Bianucci, G., C. Corsi e P. Spinelli: Glucagone e metabolismo lipidico. II. Effetti del glucagone sul tasso ematico delle lipoproteine e sul comportamento della reazione di Kunkel al fenolo (Osservazioni statistiche sul significato biologico di questo test turbidimetrico). Rev. Crit. Clin. Med. 65, 507 (1965).Google Scholar
  48. 48.
    — P. Spinelli e C. Corsi: Glucagone e metabolismo lipidico. I. Modificazioni della colesterolemia totale e delle sue frazioni da stimolo glucagonico. Rev. Crit. Clin. Med. 65, 428 (1965).Google Scholar
  49. 49.
    Bieck, P., K. Stock, and E. Westermann: Lipolytic action of serotonin in vitro. Life Sci. 5, 2157 (1966).Google Scholar
  50. 50.
    Bierich, J. R., u. B. Kornatz-Stegmann: Zur Entstehung der spontanhypoglykämischen Krämpfe. Mschr. Kinderheilk. 102, 49 (1954).PubMedGoogle Scholar
  51. 51.
    Bintliff, S. J., R. E. Condon, and H. N. Harkins: Effect of glucagon on gastric secretion in the rat with pyloric occlusion. J. surg. Res. 3, 318 (1963).PubMedGoogle Scholar
  52. 52.
    Bishop, J. S., and J. Larner: Insulin activation of liver UDPG-glycogen transferase. Fed. Proc. 26, 317 (1967).Google Scholar
  53. 53.
    — —Rapid activation-inactivation of liver uridine diphosphate glucose-glycogen transferase and phosphorylase by insulin and glucagon in vivo. J. biol. Chem. 242, 1354 (1967).PubMedGoogle Scholar
  54. 54.
    Bitensky, M. W., and S. R. Burstein: Effect of cyclic adenosine monophosphate and melanocyte-stimulating hormone on frog skin in vitro. Nature (Lond.) 208, 1282 (1965).PubMedGoogle Scholar
  55. 55.
    Björkman, N., C. Hellerström, and B. Hellman: The ultrastructure of the islets of Langerhans in normal and obese-hyperglycemic mice. Z. Zellforsch. 58, 803 (1963).PubMedGoogle Scholar
  56. 56.
    — — —, and B. Peterson: The cell types in the endocrine pancreas of the human fetus. Z. Zellforsch. 72, 425 (1966).PubMedGoogle Scholar
  57. 57.
    Bjöntorp, P.: Effect of ketone bodies on lipolysis in adipose tissue in vitro. J. Lipid Res. 7, 621 (1966).Google Scholar
  58. 58.
    Blanchard, M. H., and M. V. King: Evidence of association of glucagon from optical rotatory dispersion and concentration-difference spectra. Biochem. biophys. Res. Commun. 25, 298 (1966).PubMedGoogle Scholar
  59. 59.
    Blecher, M.: Evidence for the involvement of cyclic-3′,5′-adenosine monophosphate in glucose utilization by isolated rat epididymal adipose cells. Biochem. biophys. Res. Commun. 27, 560 (1967).PubMedGoogle Scholar
  60. 60.
    Bleicher, S. J., L. Farber, A. Lewis, and M. G. Goldner: Electrolyte-activated lipolysis in vitro: modifying effect of calcium. Metabolism 15, 742 (1966).PubMedGoogle Scholar
  61. 61.
    Bloodworth, J. M. B., and D. W. Elliott: The histochemistry of pancreatic islet cell lesions. J. Amer. med. Ass. 183, 1011 (1963).Google Scholar
  62. 62.
    Blumenthal, M. D., S. Abraham, and I. L. Chaikoff: Dietary control of liver glucokinase in the normal rat, Arch. Biochem. 104, 215 (1964).PubMedGoogle Scholar
  63. 63.
    Bonsignore, D., C. Canonica, O. Sartori e L. Lenzerini: Effetti del digiuno e dell’irradiazione sulla attività polisaccaride-fosforilasica epatica in ratti. Boll. Soc. ital. Biol. sper. 39, 1664 (1963).PubMedGoogle Scholar
  64. 64.
    Borrebaek, B.: Increase in epididymal adipose tissue hexokinase activity induced by glucose and insulin. Biochim. biophys. Acta (Amst.) 128, 211 (1966).PubMedGoogle Scholar
  65. 65.
    Bottermann, P., K. Schwarz, M. M. Forell, H. Stahlheber u. A. Souvatzoglou: Stimulierung der Insulinsekretion durch Secretin beim Menschen. Klin. Wschr. 45, 52 (1967).PubMedGoogle Scholar
  66. 66.
    Bowman, R. H.: Effects of diabetes, fatty acids and ketone bodies on tricarboxylic acid cycle metabolism in the perfused rat heart. J. biol. Chem. 241, 3041 (1966).PubMedGoogle Scholar
  67. 67.
    Bowness, J. M.: Epinephrine: cascade reactions and glycogenolytic effect. Science 152, 1370 (1966).PubMedGoogle Scholar
  68. 68.
    Boyns, D. R., R. J. Jarrett, and H. Keen: Intestinal hormones and plasma insulin: an insulinotropic action of secretin. Brit. med. J. 1967 I, 676.Google Scholar
  69. 69.
    Bradshaw, P. J., O. S. Cullimore, and E. F. Beach: Response to alloxan modified by partial pancreatectomy. Diabets 7, 136 (1958).Google Scholar
  70. 70.
    Brolin, S. E., A. Ohlsson, and E. Borglund: An approach to the quantitative histochemistry of the A-cells in the pancreatic islets. J. Histochem. Cytochem. 14, 49 (1966).PubMedGoogle Scholar
  71. 71.
    Brown, B. I., and D. H. Brown: Lack of an α-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc. nat. Acad. Sci. (Wash.). 56, 725 (1966).PubMedGoogle Scholar
  72. 72.
    Brown, D. H., B. Illingworth, and C. F. Cori: The mechanism of the de novo synthesis of polysaccharide by phosphorylase. Proc. nat. Acad. Sci. (Wash.) 47, 479 (1961).PubMedGoogle Scholar
  73. 73.
    — — —Combined action of oligo-1,4 → 1,4-glucan-transferase and amylo-1,6-glucosidase in debranching glycogen. Nature (Lond.) 167, 980 (1963).Google Scholar
  74. 74.
    Brown, J., D. M. Miller, M. T. Holloway, and G. D. Leve: Hexokinase isoenzymes in liver and adipose tissue of man and dog. Science 155, 205 (1967).PubMedGoogle Scholar
  75. 75.
    Bruni, B.: La curva glicemica da carcio endovenoso di glucagone quale sussidio diagnostico nelle malattie endocrino-metaboliche. Minerva med. 57, 3378 (1966).PubMedGoogle Scholar
  76. 76.
    Impiego clinico-terapeutico del glucagone. Minerva med. 57, 3598 (1966).PubMedGoogle Scholar
  77. 77.
    Bueding, E., E. Bülbring, H. Kuriyama, and G. Gercken: Lack of activation of phosphorylase by adrenaline during its physiological effect on intestinal smooth muscle. Nature (Lond.) 196, 944 (1963).Google Scholar
  78. 78.
    — R. W. Butcher, J. Hawkins, A. R. Timms, and E. W. Sutherland jr.: Effect of epinephrine on cyclic adenosine 3′5′-phosphate and hexose phosphates in intestinal smooth muscle. Biochem. biophys. Acta (Amst.) 115, 173 (1966).PubMedGoogle Scholar
  79. 79.
    Burch, H. B., O. H. Lowry, A. M. Kuhlman, J. Skerjance, E. J. Diamant, S. R. Lowry, and P. von Dippe: Changes in patterns of enzymes of carbohydrate metabolism in the developing rat liver. J. biol. Chem. 238, 2267 (1963).PubMedGoogle Scholar
  80. 80.
    Burke, G., J. R. Finer, and L. J. Sandlow: Ulcerogenic tumor of the pancreas and hyperparathyroidism. Gastroenterology 47, 88 (1964).PubMedGoogle Scholar
  81. 81.
    Burns, J. J., R. A. Salvador, and L. Lemberger: Metabolic blockade by methoxamine and its analogs. Ann. N. Y. Acad. Sci. 139, 833 (1967).PubMedGoogle Scholar
  82. 82.
    Burns, T. W., C. N. Hales, A. S. Hartree, and P. E. Langley: Studies on lipolysis using isolated human adipose tissue cells. Sixth Congr. Intern. Diabetes Feder., Excerpta Med., I.C.S. No 140, 158 (1967).Google Scholar
  83. 83.
    Butcher, R. W.: Cyclic 3′,5′-AMP and the lipolytic effects of hormones on adipose tissue. Pharmacol. Rev. 18, 237 (1966).PubMedGoogle Scholar
  84. 84.
    — R. J. Ho, H. C. Menz, and E. W. Sutherland jr.: Adenosine 3′,5′-monophosphate in biological materials. II. The measurement of adenosine 3′,5′-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine. J. biol. Chem. 240, 4515 (1965).PubMedGoogle Scholar
  85. 85.
    — J. G. T. Sneyd, C. R. Park, and E. W. Sutherland jr.: Effect of insulin on adenosine 3′,5′-monophosphate in the rat epididymal fat pad. J. biol. Chem. 241, 1651 (1966).PubMedGoogle Scholar
  86. 86.
    —, and E. W. Sutherland jr.: The effects of the catecholamines, adrenergic blocking agents, prostaglandin E, and insulin on cyclic AMP levels in the rat epididymal fat pad in vitro. Ann. N. Y. Acad. Sci. 139, 849 (1967).PubMedGoogle Scholar
  87. 87.
    Cahill, G. F. jr.: Glucagon action in isolated, perfused liver. Advanc. Enzymol. Regul. 3, 145 (1965).Google Scholar
  88. 88.
    M. G. Herrera, A. P. Morgan, J. S. Soeldner, J. Steinke, P. L. Levy, G. A. Reichard jr., and D. M. Kipnis: Hormone-fuel interrelationships during fasting. J. clin. Invest. 45, 1751 (1966).PubMedGoogle Scholar
  89. 89.
    S. Zottu, and A. S. Earle: In vivo effects of glucagon on hepatic glycogen phosphorylase and glucose-6-phosphatase. Endocrinology 60, 265 (1967).Google Scholar
  90. 90.
    Cameron, J. S., and J. R. Rees: The effect of small doses of insulin and glucagon on the human liver. Clin. Sci. 27, 67 (1964).PubMedGoogle Scholar
  91. 91.
    Campanacci, D., e U. Butturini: Il Glucagone in Biologia ed in Clinica. Pisa: Pacini Mariotti 1957.Google Scholar
  92. 92.
    Campbell, J., and K. S. Rastogi: Effects of glucagon and epinephrine on serum insulin and secretion in dogs. Endocrinology 79, 830 (1966).PubMedGoogle Scholar
  93. 93.
    Campbell, R. G., S. A. Hashim, and T. B. van Itallie: Octanoate-induced hypoglycemia in the dog. Clin. Res. 13, 547 (1965).Google Scholar
  94. 94.
    Canivet, J., et J. Poirier: Emploi du glucagon dans les accidents hypoglycémiques des diabétiques. Experience de 27 cas. Bull. Mem. Soc. méd. Hôp. Paris 114, 881 (1963).Google Scholar
  95. 95.
    — —Le glucagon. Étude clinique de son action hyperglycémiante. Path. et Biol. 12, 296 (1964).Google Scholar
  96. 96.
    Caramia, F.: Electron microscopic description of a third cell type in the islets of the rat pancreas. Amer. J. Anat. 112, 53 (1963).PubMedGoogle Scholar
  97. 97.
    Caren, R., and L. Corbo: Glucagon and plasma arachidonic acid. Metabolism 14, 684 (1965).PubMedGoogle Scholar
  98. 98.
    Carey, R. W., T. G. Pretlow, E. Z. Ezdinli, and J. F. Holland: Studies on the mechanism of hypoglycemia in a patient with massive intraperitoneal leiomyosarcoma. Amer. J. Med. 40, 458 (1966).PubMedGoogle Scholar
  99. 99.
    Cavallero, C., B. Malandra, and G. Galansino: Diabetogenic action of pancreatic glucagon. Nature (Lond.) 173, 585 (1954).PubMedGoogle Scholar
  100. 100.
    — —e L. Mosca: Isole Pancreatiche e Glucagone. Livorno: Poligrafico Belforte 1957.Google Scholar
  101. 101.
    —, e E. Solcia: Morfologia funzionale delle isole pancreatiche. Acta diabetol. latina. 1, 5 (1964).Google Scholar
  102. 102.
    — —, and R. Sampietro: Selective histochemistry of glucagon in the A cells of the pancreatic islets by indole methods. Intern. Symp. Pharmacol. Hormonal Polypept. Prot., Adv. exp. Med. Biol. 2 (in press).Google Scholar
  103. 103.
    Cerasi, E., and R. Luft: Plasma-insulin response to sustained hyperglycaemia induced by glucose infusion in human subjects. Lancet 1963II, 1359.Google Scholar
  104. 104.
    Cession-Fossion, A., J. Lecomte et P. Lefebvre: Sur la stimulation médullo-surrénalienne induite chez le rat par le glucagon. C.R. Soc. Biol. (Paris) 160, 723 (1966).Google Scholar
  105. 105.
    Chalmers, T. M.: Nervous and hormonal control of adipose tissue. Postgrad. med. J. 40, 464 (1964).PubMedGoogle Scholar
  106. 106.
    Chambers, J. W.: The effects of hydrocortisone, insulin, and glucagon on the uptake of alpha-aminoisobutyric acid (AIB) by the isolated perfused rat liver. Thesis, Vanderbilt University 1965. University Microfilm No 66-18.Google Scholar
  107. 107.
    Chandler, A. M., and R. O. Moore: Glycogen deposition in adipose tissue: variations in levels of glycogen-cycle enzymes during fasting and refeeding. Arch. Biochem. 108, 183 (1964).PubMedGoogle Scholar
  108. 108.
    Chapman, S. W., and J. F. Fulton: Pancreatectomy in the monkey. Amer. J. Physiol. 123, 35 (1938).Google Scholar
  109. 109.
    Charbon, G. A., J. Sebus, D. S. Kool, and M. H. Hoekstra: Augmentation by glucagon of histamine-induced gastric secretion. Gastroenterology 44, 805 (1963).PubMedGoogle Scholar
  110. 110.
    Chase, L. R., and G. D. Aurbach: Parathyroid function and the renal excretion of 3′5′-adenylic acid. Proc. nat. Acad. Sci. (Wash.) 58, 518 (1967).PubMedGoogle Scholar
  111. 111.
    Chowers, J., M. Shapiro, A. Pfau, and E. Shafrir: Serum glucose and free fatty acid responses in pheochromocytoma. Israel J. med. Sci. 2, 697 (1966).PubMedGoogle Scholar
  112. 112.
    Cicchitti, L. F.: Growth hormone and mitoses in the islets of Langerhans of the rat. Acta physiol. lat.-amer. 14, 324 (1964).PubMedGoogle Scholar
  113. 113.
    Civen, M., B. M. Trimmer, and C. B. Brown: The induction of tyrosine α-ketoglutarate and phenylalanine pyruvate transaminases in liver by glucagon. Fed. Proc. 26, 347 (1967).Google Scholar
  114. 114.
    Clark, W. C., and P. A. Owens: The influence of glucocorticoid, epinephrine and glucagon on ethanol metabolism in the dog. Arch. int. Pharmacodyn. 162, 355 (1966).PubMedGoogle Scholar
  115. 115.
    Clausen, T.: The effect of intraperitoneally injected insulin, glucagon, growth hormone and cortisol on the in vivo glycogen synthesis in the mouse-diaphragm. Acta endocr. (Kbh.) 50, 115 (1965).PubMedGoogle Scholar
  116. 116.
    Cohen, B. D.: Abnormal carbohydrate metabolism in renal disease. Blood glucose unresponsiveness to hypoglycemia, epinephrine, and glucagon. Ann. intern. Med. 57, 204 (1962).PubMedGoogle Scholar
  117. 117.
    Cohn, Z. A., and E. Parks: The regulation of pinocytosis in mouse macrophages. III. The induction of vesicle formation by nucleosides and nucleotides. J. exp. Med. 125, 457 (1967).PubMedGoogle Scholar
  118. 118.
    Collip, J. B., H. Selye, and A. Neufeld: Experimental pancreatic diabetes in the monkey. Amer. J. Physiol. 119, 289 (1937).Google Scholar
  119. 119.
    Colombo, J.-P., J. W. Weber, D. Kanameishi, and P. P. Foà: Liver phosphorylase in normal and adrenalectomized dogs treated with serotonin. Endocrinology 67, 693 (1960).PubMedGoogle Scholar
  120. 120.
    Combs, J. T., J. A. Grunt, and I. K. Brandt: New syndrome of neonatal hypoglycemia. Association with visceromegaly, macroglossia, microcephaly and abnormal umbilicus. New Engl. J. Med. 275, 236 (1966).PubMedGoogle Scholar
  121. 121.
    Conklin, J. L.: The development of the pancreas of the human foetus. Thesis University of Michigan 1961. University Microfilms, No 61-2739.Google Scholar
  122. 122.
    Coore, H. G., and P. J. Randle: Secretion of insulin by rabbit pancreas in vitro. Biochem. J. 84, 78p (1962).Google Scholar
  123. 123.
    Coquoin-Carnot, M., et J. M. Roux: Taux du glycogène et activité de la glucose-6-phosphatase dans le foie du rat à la periode périnatale. C. R. Soc. Biol. (Paris) 154, 1763 (1960).Google Scholar
  124. 124.
    — —Taux du glycogène et activité phosphorylasique dans le foie du rat à la période périnatale. C. R. Soc. Biol. (Paris) 156, 442 (1962).Google Scholar
  125. 125.
    Cornblath, M., P. J. Randle, A. Parmeggiani, and H. E. Morgan: Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J. biol. Chem. 238, 1592 (1963).PubMedGoogle Scholar
  126. 126.
    —, and S. H. Reisner: Blood glucose in the neonate and its clinical significance. New Engl. J. Med. 273, 378 (1965).Google Scholar
  127. 127.
    Costopanagiotis, A. A., J. Preston and B. Weinstein: Amino acids and peptides. V. Synthesis of the C-terminal tripeptide sequence (A27–A29) of glucagon. J. organic Chem. 31, 3398 (1966).Google Scholar
  128. 128.
    Cox, R. W., E. D. Henley, H. T. Narahara, P. P. van Arsdel, and R. H. Williams: Studies on the metabolism of glucagon-131I in rats. Endocrinology 60, 277 (1957).PubMedGoogle Scholar
  129. 129.
    Craig, J. W., and J. Larner: Influence of epinephrine and insulin on uridine diphosphate glucose-α-glucan transferase and phosphorylase in muscle. Nature (Lond.) 202, 971 (1964).PubMedGoogle Scholar
  130. 130.
    Crawford, A. L., M. J. Henderson, R. D. Hawkins, and R. E. Haist: The effect of glucagon on blood sugar and inorganic phosphorus levels in normothermic and hypothermic rats. Canad. J. Physiol. Pharmacol. 43, 601 (1965).Google Scholar
  131. 131.
    Creange, J. E., and S. Roberts: Studies on the mechanism of action of cyclic 3′,5′-adenosine monophosphate on steroid hydroxylations in adrenal homogenates. Biochem. biophys. Res. Commun. 19, 73 (1965).Google Scholar
  132. 132.
    Creutzfeldt, W., u. V. Deuticke: Beeinflussung der Insulinempfindlichkeit der eviscerierten Ratte durch Nebennierenexstirpation, Nebennierenhormone und Glukagon. Acta endocrin. (Kbh.) 39, 262 (1962).Google Scholar
  133. 133.
    Creveld, S. v.: The clinical course of glycogen disease. Canad. med. Ass. J. 88, 1 (1963).PubMedGoogle Scholar
  134. 134.
    Crockford, P. M., D. Porte jr., F. C. Wood jr., and R. H. Williams: Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man. Metabolism 15, 114 (1966).PubMedGoogle Scholar
  135. 135.
    Crone, C.: Glucose uptake in potassium-depolarized mammalian muscle. Acta physiol. scand. 68, 105 (1966).Google Scholar
  136. 136.
    Csányi, V., and O. Greengard: The regulation of basal and induced levels of liver tyrosine transaminase (TT), serine dehydratase (SD) and tryptophan pyrrolase (TP) by glucagon. Fed. Proc. 26, 347 (1967).Google Scholar
  137. 137.
    — —, and W. E. Knox: The inductions of tyrosine aminotransferase by glucagon and hydrocortisone. J. biol. Chem. 242, 2688 (1967).Google Scholar
  138. 138.
    Curry, D. M., and G. H. Beaton: Glucagon administration in pregnant rats. Endocrinology 63, 252 (1958).PubMedGoogle Scholar
  139. 139.
    Daligcon, B. C., and J. Oyama: In vivo effect of glucose, corticosterone and insulin on rat liver glycogen synthetase. Fed. Proc. 26, 484 (1967).Google Scholar
  140. 140.
    Danforth, W. H.: Glycogen synthetase activity in skeletal muscle. Interconversion of two forms and control of glycogen synthesis. J. biol. Chem. 240, 588 (1965).PubMedGoogle Scholar
  141. 141.
    David, M. A., I. W. Horvath and K. Kovacs: Über die Wirkung des Glukagons auf den Wasser-und Elektrolytstoffwechsel. Endokrinologie 39, 138 (1960).PubMedGoogle Scholar
  142. 142.
    Davidson, I. W. F., J. M. Salter, and C. H. Best: The effect of glucagon on the metabolic rate of rats. Amer. J. clin. Nutr. 8, 540 (1960).Google Scholar
  143. 143.
    Davies, D. M., A. MacIntyre, E. J. Millar, S. M. Bell, and S. K. Mehra: Need for glucagon in severe hypoglycemia induced by sulphonylurea drugs. Lancet 1967I, 363.Google Scholar
  144. 144.
    Dawkins, M. J. R.: Glycogen synthesis and breakdown in fetal and newborn rat liver. Ann. N. Y. Acad. Sci. 111, 203 (1963).PubMedGoogle Scholar
  145. 145.
    De Bodo, R. C., R. Steele, N. Altszuler, A. Dunn, and J. S. Bishop: On the hormonal regulation of carbohydrate metabolism; studies with C14 glucose. Recent Progr. Hormone Res. 19, 445 (1963).Google Scholar
  146. 146.
    Denton, R. M., and P. J. Randle: Measurement of flow of carbon atoms from glucose and glycogen glucose to glyceride glycerol and glycerol in rat heart and epididymal adipose tissue. Effects of insulin, adrenaline and alloxan-diabetes. Biochem. J. 104, 423 (1967).PubMedGoogle Scholar
  147. 147.
    — R. E. Yorke, and P. J. Randle: Measurement of concentrations of metabolites in adipose tissue and effects of insulin, alloxan-diabetes and adrenaline. Biochem. J. 100, 407 (1966).PubMedGoogle Scholar
  148. 148.
    De Plaen, J., and G. Galansino: Effects of glucagon and epinephrine in fasted dogs. Proc. Soc. exp. Biol. (N. Y.) 121, 501 (1966).PubMedGoogle Scholar
  149. 149.
    Derot, M., G. Rosselin, G. Tchobroutsky, R. Assan, and M. Rathery: Plasma insulin, glucagon, and somatotropic hormone in subjects with hypoglycemia and Langerhans adenoma. Marseille-méd. 104, 83 (1967).PubMedGoogle Scholar
  150. 150.
    Deter, R. L., and C. de Duve: Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J. Cell Biol. 33, 437 (1967).PubMedGoogle Scholar
  151. 151.
    De Venanzi, F.: Sketch of the relationship between serum inorganic phosphorus and carbohydrate metabolism. In: C. F. Cori, V. G. Foglia, L. F. Leloir and S. Ochoa, Perspectives in biology, p. 487. Elsevier Publ. Co. 1963.Google Scholar
  152. 152.
    Distribución del fósforo en el organismo bajo la influencia de diversos factores que modifican el metabolismo glucídico. Acta cient. venez. 17, 38 (1966).Google Scholar
  153. 153.
    — C. D. Altares, and J. Forero: Organ distribution of radioactive orthophosphate and total phosphorus in the rat. Diabetes 13, 609 (1965).Google Scholar
  154. 154.
    — T. Carnevali, and F. Peña: Further observations on the effect of glucagon on serum inorganic phosphorus. Acta physiol. lat.-amer. 12, 408 (1962).Google Scholar
  155. 155.
    Devrim, S., and L. Recant: Effect of glucagon on insulin release in vitro. Lancet 1966II, 1227.Google Scholar
  156. 156.
    Dewonck, G., Z. M. Bacq et G. Barac: Influence du glucagon sur l’excrétion urinaire du calcium chez le chien. C. R. Soc. Biol. (Paris) 157, 897 (1963).Google Scholar
  157. 157.
    De Wulf, H., et H. G. Hers: Activation de la glycogène-synthétase hépatique chez la souris, par administration de glycocorticoides ou de glucose. Arch. int. Physiol. 75, 362 (1967). See also Eur. J. Biochem. 2, 50, 57 (1967).PubMedGoogle Scholar
  158. 158.
    Dhalla, N. S., and P. L. McLain: Studies on the relationship between phosphorylase activation and increase in cardiac function. J. Pharmacol. exp. Ther. 155, 389 (1967).PubMedGoogle Scholar
  159. 159.
    Deiterlen-Lièvre, F.: Démonstration d’une sécretion endocrine précoce du pancréas embryonnaire de Poulet à l’aide du parabiose in vitro. C. R. Soc. Biol. (Paris) 159, 118 (1965).Google Scholar
  160. 160.
    Dixit, P. K., and A. Lazarow: Effect of alloxan on the lactic dehydrogenase (LDH) activity of the micro-dissected mammalian pancreatic islets. Metabolism 13, 285 (1964).PubMedGoogle Scholar
  161. 161.
    — I. P. Lowe, and A. Lazarow: Effect of alloxan on malic dehydrogenase activity of microdissected mammalian pancreatic islets. Proc. Soc. exp. Biol. (N. Y.) 114, 607 (1963).PubMedGoogle Scholar
  162. 162.
    Dohrmann, R. E., M. Köhler u. H. J. Uhles: Untersuchungen über die akute Glukagonwirkung auf Glykogen und β-Glucuronidaseaktivität von Leber, Milz und Nieren. Z. ges. exp. Med. 140, 178 (1966).Google Scholar
  163. 163.
    Drash, A. L.: Treatment of hypoglycemia in infancy and childhood. Modern Treatment 3, 362 (1966).PubMedGoogle Scholar
  164. 164.
    Dreiling, D. A., E. L. Bierman, A. F. Debons, P. Elsbach, and I. L. Schwartz: Effect of ACTH, hydrocortisone, and glucagon on plasma nonesterified fatty acid concentration (NEFA) in normal subjects and in patients with liver disease. Metabolism 11, 572 (1962).PubMedGoogle Scholar
  165. 165.
    Drummond, G. I., and L. Duncan: Activation of cardiac phosphorylase b kinase. J. biol. Chem. 241, 5893 (1966).PubMedGoogle Scholar
  166. 166.
    — —, and E. Hertzman: Effect of epinephrine on phosphorylase b kinase in perfused rat hearts. J. biol. Chem. 241, 5899 (1966).PubMedGoogle Scholar
  167. 167.
    Drury, D. R., A. N. Wick, and J. W. Sherrill: The effect of the hyperglycemic factor on the metabolism of glucose by the extrahepatic tissues. Diabetes 3, 129 (1954).PubMedGoogle Scholar
  168. 168.
    Dunn, A., R. Steele, N. Altszuler, J. S. Bishop, and R. C. DeBodo: Role of gluconeogenesis and glycogenolysis in response to insulin-induced hypoglycemia. Fed. Proc. 20, 192 (1961).Google Scholar
  169. 169.
    Dupré, J., and J. C. Beck: Stimulation of release of insulin by an extract of intestinal mucosa. Diabetes 15, 555 (1966).PubMedGoogle Scholar
  170. 170.
    J. D. Curtis, R. H. Unger, and J. C. Beck: Effect of secretin and pancreozymin on endocrine functions of the pancreas. Int. Symp. Pharmacol. Hormonal Polypeptides. Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  171. 171.
    — and H. Ketterer: Insulin stimulating factors of the G. I. tract. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  172. 172.
    L. Rojas, R. H. Unger, J. J. White, and J. C. Beck: Effects of portal hyperglycemia, and a gastro-intestinal factor, on splanchnic blood insulin concentration. Proc. 26th Annual Meeting Amer. Diabetes Ass. Chicago 1966, p. 29.Google Scholar
  173. 173.
    — — J. J. White, R. H. Unger, and J. C. Beck: Effects of secretin on insulin and glucagon in portal and peripheral blood in man. Lancet 1966II, 26.Google Scholar
  174. 174.
    Earl, A. S., G. F. Cahill jr., and C. S. Hoar jr.: Studies on the relationship of glucagon (HGF) to blood pepsinogen concentrations. Ann. Surg. 146, 124 (1957).Google Scholar
  175. 175.
    Edelman, P. M., J. C. Edelman, and G. Eckstein: Insulin-like effects of adenosine 3′,5′ monophosphate (cyclic AMP) on rat striated muscle. Fed. Proc. 25, 442 (1966).Google Scholar
  176. 176.
    — —, and I. L. Schwartz: Insulin-like effects of adenosine-3′,5′-monophosphate on rat striated muscle. Nature (Lond.) 210, 1017 (1966).PubMedGoogle Scholar
  177. 177.
    —, and I. L. Schwartz: Subcellular distribution of l131-insulin in striated muscle. Amer. J. Med. 40, 695 (1966).PubMedGoogle Scholar
  178. 178.
    Eisenberg, M. M., E. R. Woodward, R. Quintana, and L. R. Dragstedt: Insulin inhibition of gastric secretion. J. surg. Res. 3, 479 (1963).PubMedGoogle Scholar
  179. 179.
    Eisenstein, A. B.: Current concepts of gluconeogenesis. Amer. J. clin. Nutr. 20, 282 (1967).PubMedGoogle Scholar
  180. 180.
    — Gluconeogenesis in the isolated rat liver: interaction of glucagon and corticosteroids. Int. Symp. Pharmacol. Hormonal Polypept. Prot. Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  181. 181.
    Ellis, S., H. L. Anderson jr., and M. A. Turtle: A study of the mechanism of action of epinephrine on liver slices. J. Pharmocol. exp. Ther. 106, 383 (1952).Google Scholar
  182. 182.
    —, and S. B. Beckett: Mechanism of the potassium mobilizing action of epinephrine and glucagon. J. Pharmacol. exp. Ther. 142, 318 (1963).PubMedGoogle Scholar
  183. 183.
    — —, and J. H. Boutwell: Dibenamine blockage of epinephrine and glucagon hyperkalemias. Proc. Soc. exp. Biol. (N. Y.) 94, 347 (1957).Google Scholar
  184. 184.
    —, and A. J. Eusebi: Dissociation of epinephrine induced hyperkalemia and hyperglycemia by adrenergic blocking drugs and theophylline; role of cyclic 3′,5′-AMP. Fed. Proc. 24, 151 (1965).Google Scholar
  185. 185.
    — B. L. Kennedy, A. J. Eusebi, and N. H. Vincent: Autonomic control of metabolism. Ann. N. Y. Acad. Sci. 139, 826 (1967).PubMedGoogle Scholar
  186. 186.
    Elrick, H., N. Whipple, Y. Arai, and C. J. Hlad jr.: Further studies on the renal action of glucagon. J. clin. Endocr. 19, 1274 (1959).PubMedGoogle Scholar
  187. 187.
    Enenkel, A. G., and L. B. Smillie: Specificity of chymotrypsin B toward glucagon. Biochemistry 2, 1449 (1963).PubMedGoogle Scholar
  188. 188.
    Epple, A.: Über Beziehungen zwischen Feinbau und Jahresperiodik des Inselorgans von Vögeln. Z. Zellforsch. 27, 731 (1961).Google Scholar
  189. 189.
    Islet cytology in urodele amphibians. Gen. comp. Endocr. 7, 207 (1966).Google Scholar
  190. 190.
    — Comparative anatomy, embryology and endocrinology of the alpha cell. Res. Symp. on Glucagon, San Francisco, Oct. 7–7 (1966).Google Scholar
  191. 191.
    Erbengi, T.: Untersuchungen an dem Inselorgan der Haustaube. Endokrinologie 47, 51 (1965).Google Scholar
  192. 192.
    Etzwiller, D. D.: Effect of glucagon hydrochloride on hypoglycemia of juvenile diabetics. J. Amer. med. Ass. 183, 795 (1963).Google Scholar
  193. 193.
    Exton, J. H.: Effects of glucagon on gluconeogenesis. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  194. 194.
    — L. S. Jefferson, R. W. Butcher, and C. R. Park: Gluconeogensis in the perfused liver. The effects of fasting, alloxan diabetes, glucagon, epinephrine, adenosine 3′,5′-monophosphate and insulin. Amer. J. Med. 40, 709 (1966).PubMedGoogle Scholar
  195. 195.
    L. S. Jefferson jr., and C. R. Park: Effects of insulin antiserum and insulin on glucose production and gluconeogenesis in liver. Fed. Proc. 25, 584 (1966).Google Scholar
  196. 196.
    —, and C. R. Park: Gluconeogenesis in liver; effects of adrenalectomy, cortisol and glucagon. Fed. Proc. 24, 537 (1965).Google Scholar
  197. 197.
    — — The stimulation of gluconeogenesis from lactate by epinephrine, glucagon, and cyclic 3′,5′-adenylate in the perfused rat liver. Pharmacol. Rev. 18, 181 (1966).PubMedGoogle Scholar
  198. 198.
    Control of gluconeogenesis in liver. J. biol. Chem. 242, 2622 (1967).PubMedGoogle Scholar
  199. 199.
    Ezdinli, E. Z., and J. E. Sokal: Comparison of glucagon and epinephrine effects in the dog. Endocrinology 78, 47 (1966).PubMedGoogle Scholar
  200. 200.
    Fagundes, L. A., and R. B. Cohen: The effect of nutritional state on phosphorylase activity in the liver; a histochemical study. J. Histochem. Cytochem. 13, 553 (1965).PubMedGoogle Scholar
  201. 201.
    Fain, J. N.: Effect of puromycin on incubated adipose tissue and its response to dexamethasone, insulin, and epinephrine. Biochim. biophys. Acta (Amst.) 84, 636 (1964).PubMedGoogle Scholar
  202. 202.
    Effects of dexamethasone and 2-deoxy-d-glucose on fructose and glucose metabolism by incubated adipose tissue. J. biol. Chem. 239, 958 (1964).PubMedGoogle Scholar
  203. 203.
    Adrenergic blockade of hormone-induced lipolysis in isolated fat cells. Ann. N. Y. Acad. Sci. 139, 879 (1967).PubMedGoogle Scholar
  204. 204.
    Fain, J. N., V. P. Kovacev, and R. O. Scow: Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. J. biol. Chem. 240, 3522 (1965).PubMedGoogle Scholar
  205. 205.
    — — —Antilipolytic effect of insulin in isolated fat cells of the rat. Endocrinology 78, 773 (1966).PubMedGoogle Scholar
  206. 206.
    Falck, B., and B. Hellman: Evidence for the presence of biogenic amines in pancreatic islets. Experientia (Basel) 19, 139 (1963).Google Scholar
  207. 207.
    — —A fluorescent reaction for monoamines in the insulin producing cells of the guinea pig. Acta endocr. (Kbh.) 45, 133 (1964).PubMedGoogle Scholar
  208. 208.
    Falkmer, S.: Quelques aspects comparatifs des cellules A pancréatiques et du glucagon. Ann. Endocr. (Paris). 27, 321 (1966).Google Scholar
  209. 209.
    — B. Hellman, and G. E. Voigt: On the agranular cells in the pancreatic islet tissue of the marine teleost Cottus scorpius. Acta path. microbiol. scand. 60, 47 (1964).PubMedGoogle Scholar
  210. 210.
    —, and A. J. Matty: Blood sugar regulation in the hagfish, Myxine glutinosa. Gen. comp. Endocr. 6, 334 (1966).PubMedGoogle Scholar
  211. 211.
    Farkas, T.: Effect of norepinephrine on adipose tissue lipase and phosphorylase activity of the frog, Rana esculenta. Chem. Abstr. 66, 7807 (1967).Google Scholar
  212. 212.
    Felber, J. P., and A. Vannotti: Effects of fat infusion on glucose tolerance and insulin plasma levels. Med. exp. 10, 153 (1964).PubMedGoogle Scholar
  213. 213.
    Feldman, S., N. Friedman, and H. E. Wertheimer: Gluconeogenesis following hypothalamic stimulation. Nature (Lond.) 210, 860 (1966).PubMedGoogle Scholar
  214. 214.
    Felts, P. W., O. B. Crofford, and C. R. Park: Effect of infused ketone bodies on glucose utilization in the dog. J. clin. Invest. 43, 638 (1964).PubMedGoogle Scholar
  215. 215.
    Feruglio, F. S., L. Chiandussi, F. Greco, L. Cesano, P. G. Cologno, G. Sardi e A. Ramello: Effetto dell’infusione di glucagone sul metabolismo periferico ed epato-splancnico dei glicidi nei soggetti normali e nei cirrotici. Minerva med. 56, 1173 (1965).PubMedGoogle Scholar
  216. 216.
    — — F. Pupita, F. Greco, L. Cesano, C. Gagna, G. Sardi e S. Sartoris: Effetto dell’infusione di glucagone sul metabolismo periferico ed epatosplancnico dei lipidi nei soggetti normali e nei cirrotici. Minerva med. 56, 1215 (1965).PubMedGoogle Scholar
  217. 217.
    — F. Greco, L. Cesano, P. G. Cologno, G. Sardi, and L. Chiandussi: The effects of glucagon on systemic and hepatosplanchnic hemodynamics and on net peripheral and hepatosplanchnic balance of glucose, lactic and pyruvic acids in normal subjects and cirrhotics. Clin. Sci. 30, 43 (1966).PubMedGoogle Scholar
  218. 218.
    Field, J. B., H. E. Williams, and G. E. Mortimore: Studies on the mechanism of ethanol-induced hypoglycemia. J. clin. Invest. 42, 497 (1963).PubMedGoogle Scholar
  219. 219.
    Field, R. A.: Glycogen deposition diseases. In: J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson (eds.), The metabolic basis of inherited disease, 2nd ed., p. 141. New York: McGraw-Hill Book Co. 1966.Google Scholar
  220. 220.
    Finder, A. G., T. Boyme, and W. C. Shoemaker: Relationship of hepatic potassium efflux to phosphorylase activation induced by glucagon. Amer. J. Physiol. 206, 738 (1964).PubMedGoogle Scholar
  221. 221.
    Findor, J., and E. Hultman: The effect of glucagon, epinephrine and vasopressine on the plasma concentration and renal excretion of electrolytes in man. Scand. J. clin. Lab. Inevst. 14, 59 (1962).Google Scholar
  222. 222.
    Finger, K. F., J. C. Page, and D. R. Feller: Influence of various agonists and antagonists on the release of free fatty acids from adipose tissue in vitro. Biochem. Pharmacol. 15, 1023 (1966).PubMedGoogle Scholar
  223. 223.
    Fischer, E. H., and E. G. Krebs: Relation of structure to function of muscle phosphorylase. Fed. Proc. (Symp.) 25, 1511 (1966).PubMedGoogle Scholar
  224. 224.
    Flatt, J. P., and E. G. Ball: Studies on the metabolism of adipose tissue. XV. An evaluation of the major pathways of glucose catabolism as influenced by insulin and epinephrine. J. biol. Chem. 239, 675 (1964).PubMedGoogle Scholar
  225. 225.
    Floyd, J. C. jr., S. S. Fajans, J. W. Conn, R. F. Knopf, and J. Rull: Insulin secretion in response to protein ingestion. J. clin. Invest. 45, 1479 (1966).PubMedGoogle Scholar
  226. 226.
    — — — — — Stimulation of insulin secretion by amino acids. J. clin. Invest. 45, 1487 (1966).PubMedGoogle Scholar
  227. 227.
    Foà, P. P.: Glucagon. In: G. Pincus, K. V. Thimann and E. B. Astwood, (eds.), The hormones, vol. 4, p. 531. New York: Academic Press 1964.Google Scholar
  228. 228.
    The function of glucagon in health and disease. In: T. Panos (ed.), Juvenile diabetes mellitus, Ross Conf. Ped. Res. 51, 31 (1965).Google Scholar
  229. 229.
    Diagnostic and functional tests for the study of carbohydrate metabolism. In: H. Bartelheimer, W. Heyde u. W. Thorn (Hrsg.), d-glucose and verwandte Verbindungen in Medizin und Biologie, S. 667. Stuttgart: Ferdinand Enke 1966.Google Scholar
  230. 230.
    —The study of carbohydrate metabolism. Part I. Biological and chemical methods. In: Handbook of experimental Pharmacology, N. S., vol. XVI/15, p. 1. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  231. 231.
    — The role of glucagon on health and disease. Intern. Symp. Pharmacol. Hormonal Polypept. Prot., Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  232. 232.
    —, and G. Galansino: Glucagon. Chemistry and function in health and disease. Springfield: Ch. C. Thomas 1962.Google Scholar
  233. 233.
    —, and T. A. I. Grillo: The study of carbohydrate metabolism. Part II. Histological and histochemical methods. In: Handbook of experimental Pharmacology, N. S., vol. XVI/15, p. 107. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  234. 234.
    — — H. Kirkman, P. J. Lefebvre, A. S. Luyckx, J. C. Sodoyez, and A. J. Whitty: Biologic properties of a transplantable islet-cell tumor of the pancreas. Sixth Congr. Intern. Diabetes Federation, Stockholm 1967.Google Scholar
  235. 235.
    — M. Melli, C. K. Berger, D. Billinger, and G. G. Guidotti: Action of insulin on chick embryo heart. Fed. Proc. (Symp.) 24, 1046 (1965).PubMedGoogle Scholar
  236. 236.
    Fong, C. T. O., R. R. Becker, and D. D. Louie: An unusual reactivity of glucagon to diisopropylphosphorofluoridate. Biochim. biophys. Acta (Amst.) 90, 619 (1964).PubMedGoogle Scholar
  237. 237.
    Frasier, S. D., F. G. Smith jr., and A. Nash: The use of glucagon-gel in idiopathic spontaneous hypoglycemia of infancy. Pediatrics 35, 120 (1965).PubMedGoogle Scholar
  238. 238.
    Freedland, R. A., T. L. Cunliffe, and J. G. Zinkl: The effect of insulin on enzyme adaptations to diets and hormones. J. biol. Chem. 241, 5448 (1966).PubMedGoogle Scholar
  239. 239.
    Freinkel, N., D. L. Singer, R. A. Arky, S. J. Bleicher, J. B. Anderson, and C. K. Silbert: Alcohol hypoglycemia. I. Carbohydrate metabolism of patients with clinical alcohol hypoglycemia and the experimental reproduction of the syndrome with pure ethanol. J. clin. Invest. 42, 1112 (1963).PubMedGoogle Scholar
  240. 240.
    Frerichs, H., and E. G. Ball: Studies on the metabolism of adipose tissue. XI. Activation of phosphorylase by agents which stimulate lipolysis. Biochemistry 1, 501 (1962).PubMedGoogle Scholar
  241. 241.
    — U. Reich u. W. Creutzfeldt: Insulinsekretion in vitro. I. Hemmung der glucoseinduzierten Insulinabgabe durch Insulin. Klin. Wschr. 43, 136 (1965).PubMedGoogle Scholar
  242. 242.
    Fridland, A., and V. N. Nigam: Effects of G6P, 2-deoxy-G6P and UMP on phosphorylase and glycogen synthetase of pigeon liver. Arch. Biochem. 111, 477 (1965).PubMedGoogle Scholar
  243. 243.
    Fried, G. H., and W. Antopol: Enzymatic activities in tissues of obese-hyperglycemic mice. Amer. J. Physiol. 211, 1321 (1966).PubMedGoogle Scholar
  244. 244.
    Friedmann, B., E. H. Goodman jr., and S. Weinhouse: Liver glycogen synthesis in intact alloxan diabetic rats. J. biol. Chem. 238, 2899 (1963).PubMedGoogle Scholar
  245. 245.
    — — —Effects of insulin and fatty acids on gluconeogenesis in the rat. J. biol. Chem. 242, 3620 (1967).PubMedGoogle Scholar
  246. 246.
    Friend, J. A. R., and C. N. Hales: Spontaneous hypoglycemia and sarcoma. Acta endocr. (Kbh.) 50, 233 (1965).PubMedGoogle Scholar
  247. 247.
    Frohman, L. A., E. Z. Ezdinli, and R. Javid: Effect of vagal stimulation on insulin secretion. Proc. 26th Ann. Meet. Amer. Diabetes Ass., Chicago 1966, p. 19.Google Scholar
  248. 248.
    — — —Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes 16, 443 (1967).PubMedGoogle Scholar
  249. 249.
    Fujita, T.: The identification of the argyophil cells of pancreatic islets with D-cells. Arch. Histol. jap. 25, 189 (1964).PubMedGoogle Scholar
  250. 250.
    Gagliardino, J. J., and J. M. Martin: Studies on the mechanism of insulin release. Metabolism 15, 1068 (1966).PubMedGoogle Scholar
  251. 251.
    Galansino, G., G. D’Amico, D. Kanameishi, F. G. Berlinger, and P. P. Foà: Hyperglycemic substances originating in the pancreato-duodenal area. Amer. J. Physiol. 198, 1059 (1960).PubMedGoogle Scholar
  252. 252.
    — R. Litta-Modignani, and P. P. Foà: Studies on the release of serotonin and catecholamines in the pancreato-duodenal area. Proc. Soc. exp. Biol. (N. Y.) 112, 542 (1963).PubMedGoogle Scholar
  253. 253.
    Garcia, A., J. R. Williamson, and G. F. Cahill jr.: Studies on the perfused rat liver. II. Effect of glucagon on gluconeogenesis. Diabetes 15, 188 (1966).PubMedGoogle Scholar
  254. 254.
    Garland, P. B., and P. J. Randle: Effects of alloxan diabetes and adrenaline on concentrations of free fatty acids in rat heart and diaphragm muscles. Nature (Lond.) 199, 381 (1963).PubMedGoogle Scholar
  255. 255.
    Girod, C., et J. C. Czyba: Variation topographiques due pourcentage des cellules A et B dans les îlots de Langerhans chez le Singe Macacus irusF. Cuv. C. R. Soc. Biol. (Paris) 157, 1591 (1963).Google Scholar
  256. 256.
    — —Influence de la thyroxine sur les cellules A et B des îlots de Langerhans, chez le Singe Macacus irus F. Cuv. C. R. Soc. Biol. (Paris) 158, 1351 (1964).Google Scholar
  257. 257.
    Gizelmann, R.: Glukagonprobleme bei der Glykogenspeicherkrankheit. Helv. paediat. Acta 12, 425 (1957).Google Scholar
  258. 258.
    Glasser, S. R., and J. L. Izzo: The influence of adrenalectomy on the metabolic actions of glucagon in the fasted rat. Endocrinology 70, 54 (1962).PubMedGoogle Scholar
  259. 259.
    Gnudi, A., e C. Coscelli: È la surrenale mediatrice dell’azione lipomobilizzante indotta dal glucagone? Ateneo parmense 33, 81 (1962).Google Scholar
  260. 260.
    — —e C. Carnevali: Sull’intervento della surrenale nella mobilizzazione degli acidi grassi non esterificati indotta dal glucagone. Ateneo parmense 33, 207 (1962).Google Scholar
  261. 261.
    Godlowski, Z. Z., and J. C. Calandra: Hypoglycemic effect of tolbutamide mediated by argentaffine cells. J. appl. Physiol. 15, 684 (1960).PubMedGoogle Scholar
  262. 262.
    Goetz, F. C.: The regulation of insulin secretion. Minn. Med. 50, 321 (1967).PubMedGoogle Scholar
  263. 263.
    — J. W. Maney and B. Z. Greenberg: The regulation of insulin secretion: Effects of the infusion of glucose, ribose, and other sugars into the portal veins of dogs. J. Lab. clin. Med. 69, 537 (1967).PubMedGoogle Scholar
  264. 264.
    Goldemberg, S. H.: Reactions of glycogen synthesis and of glycolysis. In: H. Bartelheimer, W. Heyde u. W. Thorn (Hrsg.), d-glucose and verwandte Verbindungen in Medizin und Biologie, S. 292. Stuttgart: Ferdinand Enke 1966.Google Scholar
  265. 265.
    Goldfien, A., R. Moore, M. S. Zileli, L. L. Havens, L. Boling, and G. W. Thorn: Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycemia in man. J. clin. Endocr. 21, 296 (1961).PubMedGoogle Scholar
  266. 266.
    — M. S. Zileli, R. H. Despointes, and J. E. Bethune: The effect of hypoglycemia on the adrenal secretion of epinephrine and norepinephrine in the dog. Endocrinology 62, 749 (1958).PubMedGoogle Scholar
  267. 267.
    Goldman, J. K., and G. F. Cahill jr.: Insulin effect on glucose-C14 incorporation into rat liver and adipose tissue in vivo. Metabolism 13, 572 (1964).PubMedGoogle Scholar
  268. 268.
    Goodman, H. M., and G. A. Bray: Role of thyroid hormones in lipolysis. Amer. J. Physiol. 210, 1053 (1966).PubMedGoogle Scholar
  269. 269.
    Goodner, C. J., and P. C. Chu: The lack of functional suppression of beta cells after prolonged insulin replacement in the rat. Clin. Res. 15, 319 (1967).Google Scholar
  270. 270.
    Goodridge, A. G.: The effect of insulin, glucagon and prolactin on lipid synthesis and related metabolic activity in migratory and nonmigratory finches. Comp. Biochem. Physiol. 13, 1 (1964).PubMedGoogle Scholar
  271. 271.
    —, and E. G. Ball: Studies on the metabolism of adipose tissue. XVIII. In vitro effects of insulin, epinephrine and glucagon on lipolysis and glycolysis in pigeon adipose tissue. Comp. Biochem. Physiol. 16, 367 (1965).PubMedGoogle Scholar
  272. 272.
    Gorbman, A., and H. A. Bern: A textbook of comparative endocrinology. New York: John Wiley & Sons, Inc. 1962.Google Scholar
  273. 273.
    Gordon, R., S. Spector, A. Sjoerdsma, and S. Udenfriend: Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J. Pharmacol. exp. Ther. 153, 440 (1966).PubMedGoogle Scholar
  274. 274.
    Gössner, W.: Zur Enzymhistochemie der Langerhansschen Inseln. Verh. dtsch. ges. Path. 48, 125 (1958).Google Scholar
  275. 275.
    Gottstein, U., K. Held, H. Sebening u. G. Walpurger: Der Glucoseverbrauch des menschlichen Gehirns unter dem Einfluß intravenöser Infusionen von Glucose, Glucagon und Glucose-Insulin. Klin. Wschr. 43, 965 (1965).PubMedGoogle Scholar
  276. 276.
    Grahame-Smith, D. G., R. W. Butcher, R. L. Ney, and E. W. Sutherland: Adenosine-3′,5′-monophosphate (cyclic AMP) as the mediator of the action of ACTH on the adrenal cortex. Clin. Res. 15, 259 (1967).Google Scholar
  277. 277.
    Grande, F., W. F. Prigge, and C. A. Assimacopoulos: Fat-mobilizing effect of glucagon in birds. Fed. Proc. 26, 436 (1967).Google Scholar
  278. 278.
    Greengard, O., and G. T. Baker: Glucagon, starvation, and the induction of liver enzymes by hydrocortisone. Science 154, 1461 (1966).PubMedGoogle Scholar
  279. 279.
    —, and H. K. Dewey: Initiation by glucagon of the premature development of tyrosine aminotransferase, serine dehydratase, and glucose-6-phosphatase in fetal rat liver. J. biol. Chem. 242, 2986 (1967).PubMedGoogle Scholar
  280. 280.
    Gregg, R. V.: The gastric argentaffin cell population of the rat. J. Morph. 119, 81 (1966).PubMedGoogle Scholar
  281. 281.
    Greider, M. H., D. W. Elliott, and R. M. Zollinger: An electron microscope study of the islet cell adenomas. J. Amer. med. Ass. 186, 566 (1963).Google Scholar
  282. 282.
    Grillo, T. A. I.: The ontogenesis of the endocrine pancreas and carbohydrate metabolism. In: R. L. de Haan and H. Ursprung (eds.), Organogenesis, p. 513. New York: Holt, Rinehart & Winston, Inc. 1965.Google Scholar
  283. 283.
    —, and D. L. Baxter-Grillo: The activity of phosphorylase and the effect of glucagon on the yolk sac of the chick embryo. Gen. comp. Endocr. 7, 420 (1966).PubMedGoogle Scholar
  284. 284.
    —, G. Okuno, G. Guidotti, S. Price, and P. P. Foà: Studies on the ontogenesis of the pancreas. In: S. E. Brolin, B. Hellman and H. Knutson (eds.), The structure and metabolism of the pancreatic islets, p. 157. Oxford: Pergamon Press 1964.Google Scholar
  285. 285.
    — — S. Price, and P. P. Foà: The activity of uridine diphosphate glucoseglycogen synthetase in some embryonic tissues. J. Histochem. Cytochem. 12, 275 (1964).PubMedGoogle Scholar
  286. 286.
    — A. J. Whitty, H. Kirkman, P. P. Foà, and S. D. Kobernick: Biological properties of a transplantable pancreatic tumor of the golden hamster. I. Histology and histochemistry. Diabetes 16, 409 (1967).Google Scholar
  287. 287.
    Grodsky, G. M., and L. L. Bennett: Time sequence in the release of insulin: The effect of glucose, glucagon and potassium. Proc. 26th Ann. Meet. Amer. Diabetes Ass., Chicago 1966, p. 18.Google Scholar
  288. 288.
    — —Cation requirements for insulin secretion in the isolated perfused pancreas. Diabetes 15, 910 (1966).PubMedGoogle Scholar
  289. 289.
    — — D. F. Smith, and F. C. Schmid: Effect of pulse administration of glucose or glucagon on insulin secretion in vitro. Metabolism 16, 222 (1967).PubMedGoogle Scholar
  290. 290.
    Groen, J. J., S. Eldar, E. Havivi, and I. Chowers: Epinephrine as a physiological antagonist of muscle glucose uptake. Israel J. med. Sci. 2, 690 (1966).PubMedGoogle Scholar
  291. 291.
    Grollman, A., W. E. McCaleb, and F. N. White: Glucagon deficiency as a cause of hypoglycemia. Metabolism 13, 686 (1964).PubMedGoogle Scholar
  292. 292.
    Grossbard, L., and R. T. Schimke: Multiple hexokinases of rat tissues. Purification and comparison of soluble forms. J. biol. Chem. 241, 3546 (1966).PubMedGoogle Scholar
  293. 293.
    Grover, R. W., and N. Arikian: The effect of intralesional insulin and glucagon in acne vulgaris. J. invest. Derm. 40, 259 (1963).PubMedGoogle Scholar
  294. 294.
    Gullick, H. D.: The effect of glucagon and of glucose on epinephrine-induced changes in plasma lipids and lipolytic activity. Proc. 26th Ann. Meet. Amer. Diabetes Ass., Chicago 1966, p. 32.Google Scholar
  295. 295.
    — Dual role of glucagon in lipid metabolism. Intern. Symp. Pharmacol. Hormonal Polypept. Prot. Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  296. 296.
    Gutman, A., and E. Shafrir: Metabolic influences on enzymes of glycogen synthesis and breakdown in adipose tissue. Amer. J. Physiol. 207, 1215 (1964).PubMedGoogle Scholar
  297. 297.
    Gwinup, G., R. C. Byron, W. H. Roush, F. A. Kruger, and G. J. Hamwi: Effect of nibbling versus gorging on serum lipids in man. Amer. J. clin. Nutr. 13, 209 (1963).PubMedGoogle Scholar
  298. 298.
    — — — — —Effect of nibbling versus gorging on glucose tolerance. Lancet 1963 II, 165.Google Scholar
  299. 299.
    Habdanian, H., and W. H. Fishman: Divergent effects of actinomycin D on cortisol and on glucose stimulation of glycogenesis in mouse liver. Biochem. J. 102, 103 (1967).Google Scholar
  300. 300.
    Haessler, H. A., and J. D. Crawford: Lipolysis in homogenates of adipose tissue: an inhibitor found in fat from obese rats. Science 154, 909 (1966).PubMedGoogle Scholar
  301. 301.
    Haft, D. E.: Effects of insulin on glucose metabolism by the perfused normal rat liver. Amer. J. Physiol. 213, 219 (1967).Google Scholar
  302. 302.
    Hagen, J. H.: Effect of glucagon on the metabolism of adipose tissue. J. biol. Chem. 236, 1023 (1961).PubMedGoogle Scholar
  303. 303.
    Hales, C. N.: The glucose-fatty acid cycle and the aetiology of diabetes. Proc. Nutr. Soc. 25, 61 (1966).PubMedGoogle Scholar
  304. 304.
    Hammersteiner, K. E., A. A. Yunis, and E. G. Krebs: Studies on phosphorylase activation in the heart. J. biol. Chem. 240, 986 (1965).Google Scholar
  305. 305.
    Hanson, J., A. Ohneda, A. Eisentraut, and R. H. Unger: Characterization of gut “glucagon”. Clin. Res. 15, 43 (1967).Google Scholar
  306. 306.
    Haro, E. N., S. F. Blum, and W. W. Faloon: The glucagon response of fasting obese subjects. Metabolism 14, 977 (1965).Google Scholar
  307. 307.
    Harris, J. B., and D. Alonso: Cyclic AMP and active electrolyte transport. Fed. Proc. 22, 623 (1963).Google Scholar
  308. 308.
    Hartog, M., R. J. Havel, G. Copinschi, J. M. Earll, and B. C. Ritchie: The relationship between changes in serum levels of growth hormone and mobilization of fat during exercise in man. Quart. J. exp. Physiol. 52, 86 (1967).Google Scholar
  309. 309.
    Havel, R. J.: The neurohumoral control of lipid storage, transport and utilization. Physiology for Physicians 1, No 6 (1963).Google Scholar
  310. 310.
    Haxhe, J. J., and P. J. Kestens: A simple and efficient method for 131l labelling of insulin and glucagon. Clin. chim. Acta 8, 302 (1963).PubMedGoogle Scholar
  311. 311.
    Hazelwood, R. L., B. S. Hazelwood, and W. F. McNary: Possible hypophysial control over glycogenesis in the avian glycogen body. Endocrinology 71, 334 (1962).PubMedGoogle Scholar
  312. 312.
    Heald, P. J., P. M. McLachlan, and K. A. Rookledge: The effects of insulin, glucagon and adrenocorticotrophic hormone on the plasma glucose and free fatty acids of the domestic fowl. J. Endocr. 33, 83 (1965).PubMedGoogle Scholar
  313. 313.
    Hebert, S., et J. Verne: Le glycogène dans les hépatocytes en culture en présence des hormones pancréatiques. Ann. Histochim. 9, 93 (1964).PubMedGoogle Scholar
  314. 314.
    Heim, T., and D. Hull: Effect of proparanol on the calorigenic response in brown adipose tissue of newborn rabbits to catechol amines, glucagon, corticotropin, and cold exposure. J. Physiol. (Lond.) 187, 271 (1966).PubMedGoogle Scholar
  315. 315.
    Heimberg, M., A. Dunkerley, and T. O. Brown: Hepatic lipid metabolism in experimental diabetes. I. Release and uptake of triglycerides by perfused livers from normal and alloxan-diabetic rats. Biochim. biophys. Acta (Amst.) 125, 252 (1966).Google Scholar
  316. 316.
    Heimburg, R. L. v., and G. A. Hallenbeck: Inhibition of gastric secretion in dogs by glucagon given intraportally. Gastroenterology 47, 531 (1964).Google Scholar
  317. 317.
    Hellerström, C.: A method for the microdissection of intact pancreatic islets of mammals. Acta endocr. (Kbh.) 45, 122 (1964).Google Scholar
  318. 318.
    —, and K. Asplund: The two types of A-cells in the pancreatic islets of snakes. Z. Zellforsch. 70, 68 (1966).Google Scholar
  319. 319.
    —, and B. Hellman: Some aspects of silver impregnation of the islets of Langerhans in the rat. Acta endocr. (Kbh.) 35, 518 (1960).Google Scholar
  320. 320.
    — —Demonstration of oxidative enzymes in the human pancreas with special reference to the islets of Langerhans. Acta path. microbiol. scand. 55, 385 (1962).PubMedGoogle Scholar
  321. 321.
    Hellman, B.: The development of the mammalian pancreas. Biol. Neonat. (Basel) 9, 263 (1965/66).PubMedGoogle Scholar
  322. 322.
    —, and C. Hellerström: Cellular composition of the islets of Langerhans in the bullfrog, Rana Catesbiana. Acta anat. (Basel) 48, 149 (1962).PubMedGoogle Scholar
  323. 323.
    —, and B. Petersson: Long-term changes of the α1 and α2 cells in the islets of Langerhans of rats with alloxan diabetes. Endocrinology 72, 238 (1963).PubMedGoogle Scholar
  324. 324.
    — U. Rothman, and C. Hellerström: Identification of a specific type of α cell located in the central part of the pancreatic islets of the horse. Gen. comp. Endocr. 2, 558 (1962).Google Scholar
  325. 325.
    Helmreich, E., and C. F. Cori: The role of adenylic acid in the activation of phosphorylase. Proc. nat. Acad. Sci. (Wash.) 51, 131 (1964).PubMedGoogle Scholar
  326. 326.
    Herman, L., and T. Sato: Comparative morphology of pancreatic islets. Fed. Proc. 23, 442 (1964).Google Scholar
  327. 327.
    Hers, H. G.: α-glucosidase deficiency in generalized glycogen-storage disease (Pompe’s disease). Biochem J. 86, 11 (1963).PubMedGoogle Scholar
  328. 328.
    Glycogen storage disease. Advanc. Metab. Disorders 1, 1 (1964).Google Scholar
  329. 329.
    Hertelendy, F., L. J. Machlin, R. S. Gordon, M. Horino, and D. M. Kipnis: Lipolytic activity and inhibition of insulin release by epinephrine in the pig. Proc. Soc. exp. Biol. (N.Y.) 121, 675 (1966).PubMedGoogle Scholar
  330. 330.
    Hess, M. E., J. Shanfeld, and N. Haugaard: The effect of epinephrine on isometric tension and phosphorylase activity on the isolated rat heart. Biochem. Pharmacol. 11, 1031 (1962).PubMedGoogle Scholar
  331. 331.
    Hess, W.: Über ein endokrin inaktives Carcinom der Langerhansschen Inseln. Schweiz. med. Wschr. 76, 802 (1946).Google Scholar
  332. 332.
    Hiatt, N.: Hypoglycaemia, elevated liver glycogen and diminished liver amylase in pancreatectomized-enterectomized dogs. Nature (Lond.) 210, 423 (1966).PubMedGoogle Scholar
  333. 333.
    Hiroshige, T., and C. N. H. Long: Effect of dexamethasone on gluconeogenesis in the visceral organism. 46th Meeting Endocrine Soc. 1964, p. 100.Google Scholar
  334. 334.
    Hirschowitz, B. I.: Continuing gastric secretion after insulin hypoglycemia despite glucose injection. Amer. J. dig. Dis. 12, 19 (1967).PubMedGoogle Scholar
  335. 335.
    —, and G. Sachs: Insulin effects on gastric secretion and blood electrolytes modified by injected potassium. Amer. J. dig. Dis. 12, 7 (1967).PubMedGoogle Scholar
  336. 336.
    Hofert, J. F., and R. K. Boutwell: Effect of puromycin on hepatic glycogen phosphorylase activity. Proc. Soc. exp. Biol. (N.Y.) 121, 533 (1966).Google Scholar
  337. 337.
    Hollett, C. R., and J. V. Auditore: A lipid mobilizing substance from calf midbrain. Fed. Proc. 26, 436 (1967).Google Scholar
  338. 338.
    Holloway, S. A., and J. A. F. Stevenson: Effect of glucagon on oxygen consumption in the cold-adapted rat. Canad. J. Physiol. Pharmacol. 42, 860 (1964).Google Scholar
  339. 339.
    — —Effect of glucagon on food intake and weight gain in the young rat. Canad. J. Physiol. Pharmacol. 42, 867 (1964).Google Scholar
  340. 340.
    — —The effect of glucagon on pregnancy in the rat. Canad. J. Physiol. Pharmacol. 43, 473 (1965).Google Scholar
  341. 341.
    Honig, C. R., and C. van Nierop: The possible relationship between cyclic 3′5′ AMP and soluble cardiac relaxing substance. Physiologist 6, 203 (1963).Google Scholar
  342. 342.
    Hornbrook, K. R., and T. M. Brody: The effect of catecholamines on muscle glycogen and phosphorylase activity. J. Pharmacol. exp. Ther. 140, 295 (1963).PubMedGoogle Scholar
  343. 343.
    Hostetler, K., S. J. Cooperstein, B. R. Landau, and A. Lazarow: Pathways of glucose metabolism in the isolated islet of the goosefish in vitro. Amer. J. Physiol. 211, 1057 (1966).PubMedGoogle Scholar
  344. 344.
    Houssay, B. A., J. C. Penhos, and M. A. Luján: Blood glucose changes in reptiles after total pancreatectomy. Tex. Rep. Biol. Med. 23, 304 (1965).PubMedGoogle Scholar
  345. 345.
    Howell, R. R., D. M. Ashton, and J. B. Wyngaarden: Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid and purine abnormalities. Pediatrics 29, 553 (1962).PubMedGoogle Scholar
  346. 346.
    Howell, S. L., and K. W. Taylor: Effect of glucose concentration on incorporation of 3H leucine into insulin using isolated mammalian islets of Langerhans. Biochim. biophys. Acta (Amst.) 130, 519 (1966).PubMedGoogle Scholar
  347. 347.
    Hsia, D. Y.: Inborn errors of metabolism, 2nd ed. Chicago: Year Book Med. Publ. 1966.Google Scholar
  348. 348.
    Hug, G., J. C. Carancis, W. K. Schubert, and S. Kaplan: Glycogen storage disease, types II, III, VIII and IX. Amer. J. Dis. Child. 111, 457 (1966).Google Scholar
  349. 349.
    — W. K. Schubert, and G. Chuck: Phosphorylase kinase of the liver: deficiency in a girl with increased hepatic glycogen. Science 153, 1534 (1966).PubMedGoogle Scholar
  350. 350.
    — — —, and J. C. Garancis: Liver phosphorylase. Deactivation in a child with progressive brain disease, increased hepatic glycogen and increased urinary catecholamines. Amer. J. Med. 42, 139 (1967).PubMedGoogle Scholar
  351. 351.
    Huijing, F., S. v. Creveld, and G. Losekoot: Diagnosis of generalized glycogen storage disease (Pompe’s disease). J. Ped. 63, 985 (1963).Google Scholar
  352. 352.
    —, and J. Larner: On the effect of adenosine 3′,5′ cyclophosphate on the kinase of UDPG: α-1,4-glucan α-4-glucosyl transferase. Biochem. biophys. Res. Commun. 23, 259 (1966).PubMedGoogle Scholar
  353. 353.
    Huizenga, K. A., W.I.M. Goodrick, and W.H.I. Summerskill: Peptic ulcer with islet cell tumor. Amer. J. Med. 37, 564 (1964).PubMedGoogle Scholar
  354. 354.
    Hunninghake, D. B., D. L. Azarnoff, and D. Waxman: Drug inhibition of catecholamine-induced metabolic effects in humans. Ann. N.Y. Acad. Sci. 139, 971 (1967).PubMedGoogle Scholar
  355. 355.
    Hylton, T. A., J. Preston, and B. Weinstein: Amino acids and peptides. VI. Synthesis of heptapeptide sequence A20—A26 of glucagon. J. organic Chem. 31, 3400 (1966).Google Scholar
  356. 356.
    Ihara, N.: Enzyme histochemistry in experimental diabetes mellitus. III. Findings on several enzyme activities in pancreatic islet cells of chronic diabetic rabbits. Endocr. jap. 13, 141 (1966).Google Scholar
  357. 357.
    Ilyin, V. S., and G. V. Titova: Hormone-enzyme complex: insulin-hexokinase. Nature (Lond.) 211, 644 (1966).PubMedGoogle Scholar
  358. 358.
    Ingle, D. J., J. E. Nezamis, and L. M. Humphrey: Absence of hyperglycemic effect of glucagon in the eviscerate rat. Proc. Soc. exp. Biol. (N.Y.) 84, 232 (1953).PubMedGoogle Scholar
  359. 358a.
    Iodice, A. A.: The carboxypeptidase nature of cathepsin A. Arch. Biochem. 121, 241 (1967).PubMedGoogle Scholar
  360. 359.
    Iori, E.: Modificazione del glucosio del fegato dopo carico di glucagone in pazienti diabetici non insulinizzati. Boll. Soc. ital. Biol. sper. 41, 1143 (1965).Google Scholar
  361. 360.
    Issekutz, B. jr., H. I. Miller, and K. Rodahl: Lipid and carbohydrate metabolism during exercise. Fed. Proc. 25, 1415 (1966).PubMedGoogle Scholar
  362. 361.
    Izzo, J. L.: Effects of glucagon on gluconeogenesis. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  363. 362.
    —, and S. R. Glasser: Comparative effects of glucagon, hydrocortisone and epinephrine on the protein metabolism of the fasting rat. Endocrinology 68, 189 (1961).PubMedGoogle Scholar
  364. 363.
    — —Interrelationship of actions of glucagon and somatotropin on protein metabolism in the fasted hypophysectomized rat. Endocrinology 72, 701 (1963).PubMedGoogle Scholar
  365. 364.
    —, and A. Roncone: Fall in blood amino acids in fasted rats induced by glucagon. Fed. Proc. 25, 240 (1966).Google Scholar
  366. 365.
    Izzo, J. L., A. Roncone, and S. Hoisington: Immunoassay of glucagon using a two-antibody system (Abstract). Diabetes 14, 450 (1965).Google Scholar
  367. 366.
    Jacobowitz, D., and B.H. Marks: Effect of stress on glycogen and phosphorylase in the rat anterior pituitary. Endocrinology 75, 86 (1964).PubMedGoogle Scholar
  368. 367.
    Jansen, G. R., M. E. Zanetti, and C. F. Hutchison: Studies in lipogenesis in vivo: Fatty acid and cholesterol synthesis during starvation and re-feeding. Biochem. J. 101, 811 (1966).PubMedGoogle Scholar
  369. 368.
    Jarett, L.: In vivo and in vitro effect of glucagon on DL-leucine-1-C14 incorporation into protein of rat pancreas. Proc. Soc. exp. Biol. (N.Y.) 114, 550 (1963).PubMedGoogle Scholar
  370. 369.
    Jarrett, R. J., and H. Keen: Glucose metabolism of isolated mammalian islets of Langerhans. Lancet 1966 I, 633.Google Scholar
  371. 370.
    Jedeikin, L. A.: Glycogen and phosphorylase distribution throughout the walls of the heart and conduction system. Biochem. Pharmacol. 9, 193 (1962).Google Scholar
  372. 371.
    Regional metabolism of the heart with regard to glycogen and phosphorylase. Rev. canad. Biol. 22, 165 (1963).PubMedGoogle Scholar
  373. 372.
    Jefferson, L. S. jr.: Metabolic effects of insulin antiserum in the rat. Thesis Vanderbilt University 1966. University Microfilms, No 66-8050.Google Scholar
  374. 373.
    Jensen, H. E.: Effect of glucagon on pressure and oxygen saturation of splanchnic venous blood. Amer. J. dig. Dis. 11, 447 (1966).PubMedGoogle Scholar
  375. 374.
    —, and H. Necheles: Hemo-dynamic effects of glucagon in the splanchnic area. Illinois med. J. 130, 49 (1966).Google Scholar
  376. 375.
    Joel, C. D.: Stimulation of metabolism of rat brown adipose tissue by addition of lipolytic hormones in vitro. J. biol. Chem. 241, 814 (1966).PubMedGoogle Scholar
  377. 376.
    Johnson, I. S., and H. F. Wright: Anti-tumor activity of glucagon. Cancer Res. 19, 557 (1959).PubMedGoogle Scholar
  378. 377.
    Jordan, P. H., and R. Quintana: Insulin inhibition of gastrin-stimulated gastric secretion. Gastroenterology 47, 617 (1964).PubMedGoogle Scholar
  379. 378.
    Jorpes, E., and V. Mutt: Sekretion och glukagon som regulatorer för insulin-insöndringen till blodet. Nord. Med. 77, 301 (1967).PubMedGoogle Scholar
  380. 379.
    Jungas, R. L.: Role of cyclic-3′,5′-AMP in the response of adipose tissue to insulin. Proc. nat. Acad. Sci. (Wash.) 56, 767 (1966).Google Scholar
  381. 380.
    Kakiuchi, S., and T. W. Rall: Effects of norepinephrine and histamine on levels of adenosine 3′,5′-phosphate in brain slices. Fed. Proc. 24, 150 (1965).Google Scholar
  382. 381.
    —, and H. H. Tomizawa: Properties of a glucagon-degrading enzyme of beef liver. J. biol. Chem. 239, 2160 (1964).PubMedGoogle Scholar
  383. 382.
    Kalant, N.: The effect of glucagon on metabolism of glycine-1-C14. Arch. Biochem. 65, 469 (1956).PubMedGoogle Scholar
  384. 383.
    Kaldor, A., Z. El Baz Rihan, T. R. Nichols, and W. J. H. Butterfield: Effects of adenine and guanine on hepatic glucose release and on the action of insulin on the liver. Nature (Lond.) 203, 1186 (1964).PubMedGoogle Scholar
  385. 384.
    Kalkhoff, R. K., K. R. Hornbrook, H. B. Burch, and D. M. Kipnis: Studies on the metabolic effects of acute insulin deficiency. II. Changes in hepatic glycolytic and Krebs-cycle intermediates and pyridine nucleotides. Diabetes 15, 451 (1966).PubMedGoogle Scholar
  386. 385.
    Kappeler, H.: Zur Pharmakologie der Lipolysehemmung. 1. Wirkungsweise adenosinhaltiger Nucleoside und Nucleotide auf die Lipolyse des Fettgewebes in vitro. Diabetologia 2, 52 (1966).PubMedGoogle Scholar
  387. 386.
    Karam, J. H., S. G. Grasso, L. C. Wegienka, G. M. Grodsky, and P. H. Forsham: Effect of selected hexoses, of epinephrine and glucagon on insulin secretion in man. Diabetes 15, 571 (1966).PubMedGoogle Scholar
  388. 387.
    Katzen, H. M.: The effect of diabetes and insulin in vivo and in vitro on a low Km form of hexokinase from various rat tissues. Biochem. biophys. Res. Commun. 24, 531 (1966).PubMedGoogle Scholar
  389. 388.
    Keen, H., R. Sell, and R. J. Jarrett: A method for the study of the metabolism of isolated mammalian islets of Langerhans and some preliminary results. Diabetologia 1, 28 (1965).Google Scholar
  390. 389.
    Keller, H.-U., u. M. Staehelin: Über die Phosphorylase des Herzmuskels. Helv. physiol. pharmacol. Acta 21, 142 (1963).PubMedGoogle Scholar
  391. 390.
    Kenney, F. T.: Turnover of rat liver tyrosine transaminase in vivo: inhibition by protein synthesis-inhibitors. Fed. Proc. 26, 347 (1967).Google Scholar
  392. 391.
    Kenny, A. J., and R. R. Say: Glucagon-like activity extractable from the gastro-intestinal tract of man and other animals. J. Endocr. 25, 1 (1962).PubMedGoogle Scholar
  393. 392.
    Kern, H. F.: Die Zytologie des Inselorgans im Pankreas einiger neotener Urodelen (Megalobatrachus, Cryptobranchus, Amphiuma). Z. Zellforsch. 70, 499 (1966).PubMedGoogle Scholar
  394. 393.
    Morphologie der Alloxanwirkung bei Haien mit besonderer Berücksichtigung der Schäden im Pankreas. Z. Zellforsch. 71, 469 (1966).PubMedGoogle Scholar
  395. 394.
    Kerppola, W.: Inhibition of phosphorylase with cortisone and its activation with adrenalin in the rabbit. Endocrinology 51, 192 (1952).PubMedGoogle Scholar
  396. 395.
    Ketterer, H., J. Dupre, A. M. Eisentraut, and R. H. Unger: Insulin-releasing factors of the gastrointestinal tract. Proc. 26th Annual Meet. Amer. Diabetes Ass. Chicago 1966, p. 19.Google Scholar
  397. 396.
    A. M. Eisentraut, and R. H. Unger: Effect upon insulin secretion of physiologic doses of glucagon administered via the portal vein. Diabetes 16, 283 (1967).PubMedGoogle Scholar
  398. 397.
    Kibler, R. F.: Effects of glucagon on carbohydrate and protein metabolism in vivo. Res. Symp. on Glucagon. San Francisco, Oct. 7–8, 1966.Google Scholar
  399. 398.
    W. J. Taylor, and J. D. Myers: The effect of glucagon on net splanchnic balances of glucose, amino acid nitrogen, urea, ketones, and oxygen in man. J. clin. Invest. 43, 904 (1964).PubMedGoogle Scholar
  400. 399.
    Kim, K. S., and P. A. Shore: Mechanism of action of reserpine and insulin on gastric amines and gastric acid secretion, and the effect of monoamine oxidase inhibition. J. Pharmacol. exp. Ther. 141, 321 (1963).PubMedGoogle Scholar
  401. 400.
    King, M. V.: A low resolution structural model for cubic glucagon based on packing of cylinders. J. molec. Biol. 11, 549 (1965).PubMedGoogle Scholar
  402. 401.
    Klainer, L. M., Y.-M. Chi, S. L. Freidberg, T. W. Rall, and E. W. Sutherland: Adenyl cyclase. IV. The effect of neurohormones on the formation of adenosine 3′-5′-phosphate by preparations from brain and other tissues. J. biol. Chem. 237, 1239 (1962).PubMedGoogle Scholar
  403. 402.
    Knopf, R. F., S. S. Fajans, J. C. Floyd jr, and J. W. Conn: Comparison of experimentally induced and naturally occurring sensitivity to leucine hypoglycemia. J. clin. Endocr. 23, 579 (1963).PubMedGoogle Scholar
  404. 403.
    Kologlu, Y., L. L. Wiesel, V. Positano, and G. E. Anderson: An immune chromatographic method for assay in serum of antibodies to glucagon and insulin. Proc. Soc. exp. Biol. (N. Y.) 112, 518 (1963).PubMedGoogle Scholar
  405. 404.
    Kopetz, K., K. P. Eymer, L. Schwarz, and K. F. Weinges: Effect of insulin and of glucagon on the plasma free 17-hydroxy corticosteroids. Symp. dtsch. Ges. Endokr. 8, 365 (1962).Google Scholar
  406. 405.
    Korner, A., and M. S. Raben: Effect of aminonucleoside and puromycin on insulin and epinephrine control of fatty acid release from adipose tissue. Nature (Lond.) 203, 1287 (1964).PubMedGoogle Scholar
  407. 406.
    Kornfeld, R., and D. H. Brown: The activity of some enzymes of glycogen metabolism in fetal and neonatal guinea pig liver. J. biol. Chem. 238, 1604 (1963).PubMedGoogle Scholar
  408. 407.
    Kovacev, V. P., and R. O. Scow: Effect of hormones on fatty acid release by rat adipose tissue in vivo. Amer. J. Physiol. 210, 1199 (1966).PubMedGoogle Scholar
  409. 408.
    Krause, E. G.: Über die Wirkung von Diäthyläther auf die Aktivität der Glykogenphosphorylase und Phosphorylase b-Kinase in Herz, Skeletmuskel und Leber der Ratte. Experientia (Basel) 22, 479 (1966).PubMedGoogle Scholar
  410. 409.
    —, u. A. Wollenberger: Über die Aktivierung der Phosphorylase und die Glykolyserate im akut anoxischen Hundeherzen. Biochem. Z. 342, 171 (1965).PubMedGoogle Scholar
  411. 410.
    Kreisberg, R. A., and J. R. Williamson: Metabolic effects of glucagon in the perfused rat heart. Amer. J. Physiol. 207, 721 (1964).PubMedGoogle Scholar
  412. 411.
    Kretschy, A., u. H. Pietschmann: Die Wirkung von Glukagon bei Patienten mit Insulin-Resistenz bzw. Insulin-Allergie. Wien. Z. inn. Med. 46, 124 (1965).Google Scholar
  413. 412.
    Krulich, L., and S. M. McCann: Effect of alterations in blood sugar on pituitary growth hormone content in the rat. Endocrinology 78, 759 (1966).PubMedGoogle Scholar
  414. 413.
    Kuschke, H. J., H. Klusmann u. B. Schölkens: Untersuchungen über die Wirkung von Glucagon auf das sympathoadrenale System des Menschen. Klin. Wschr. 44, 1297 (1966).PubMedGoogle Scholar
  415. 414.
    Kushner, R. S., L. Lemli, and D. W. Smith: Zinc glucagon in the management of idiopathic hypoglycemia. J. Pediat. 63, 1111 (1963).PubMedGoogle Scholar
  416. 415.
    Lacy, P. E.: Studies of electron microscopy of secretory processes of islet cells. In: B. S. Leibel and G. A. Wrenshall (eds.), On the nature and treatment of diabetes, p. 1. Amsterdam: Excerpta Med. Found. 1965.Google Scholar
  417. 416.
    —, and M. Kostianovsky: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16, 35 (1967).PubMedGoogle Scholar
  418. 417.
    Lambert, A. E., and J. J. Hoet: Diurnal pattern of plasma insulin concentration in the human. Diabetologia 2, 69 (1965).Google Scholar
  419. 418.
    — B. Jeanrenaud, and A. E. Renald: Enhancement by caffeine of glucagon-induced and tolbutamide-induced insulin release from isolated foetal pancreatic tissue. Lancet 1967 I, 819.Google Scholar
  420. 419.
    Lardy, H. A.: Gluconeogenesis — Pathways and hormonal regulation. Harvey Lect. Ser. 60, 261 (1964–65).Google Scholar
  421. 420.
    — Cellular control of metabolism by the supply of substrate. Panel discussion. Sixth Congr. Intern. Diabetes Feder., Excerpta Med., I.C.S. (in press).Google Scholar
  422. 421.
    Larner, J.: Hormonal and nonhormonal control of glycogen metabolism. Trans. N. Y. Acad. Sci., Ser. II, 29, 193 (1967).Google Scholar
  423. 422.
    — M. Rosell-Perez, D. L. Friedman, and J. W. Craig: Insulin and the control of UDPG-α-glucan transglucosylase activity. In: W. J. Whelan and M. P. Cameron (eds.), Control of glycogen metabolism, p. 273. Boston: Little, Brown & Co. 1964.Google Scholar
  424. 423.
    Laron, Z., M. Karp, A. Pertzelan, M. Doron, and T. Waks: The effect of glucagon, epinephrine, arginine, ACTH and vasopressin on serum insulin and growth hormone concentrations in normal and abnormal conditions in children. Intern. Symp. Pharmacol. Hormonal Polypept. Prot., Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  425. 424.
    Lawrence, A. M.: Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. Proc. nat. Acad. Sci. (Wash.) 55, 316 (1966).PubMedGoogle Scholar
  426. 425.
    Glucagon provocative test for pheochromocytoma. Ann. intern. Med. 66, 1091 (1967).PubMedGoogle Scholar
  427. 426.
    Lawzenwitsch, I. v.: Topographical distribution of the islets of Langerhans in the toad Bufo arenarumHensel. Acta physiol. lat.-amer. 13, 382 (1963).Google Scholar
  428. 427.
    Lazarow, A.: Insulin synthesis, storage, release, transport and antagonism. Third research symposium of the American Diabetes Association. Diabetes 15, 281 (1966).PubMedGoogle Scholar
  429. 428.
    Leboeuf, B., S. Lochaya, N. Leboef, F. C. Wood jr., J. Mayer, and G. F. Cahill jr.: Glucose metabolism and mobilization of fatty acids by adipose tissue from obese mice. Amer. J. Physiol. 201, 19 (1961).PubMedGoogle Scholar
  430. 429.
    Lebovitz, H. E., and K. Pooler: ACTH-mediated insulin secretion: effect of aminophylline. Endocrinology 81, 558 (1967).PubMedGoogle Scholar
  431. 430.
    Lefebvre, P.: Glucagon et taux sanguin des acides gras non estérifiés chez l’homme. Ann. Endocr. (Paris) 26, 369 (1965).PubMedGoogle Scholar
  432. 431.
    The physiological effect of glucagon on fat mobilization. Diabetologia 2, 130 (1966).PubMedGoogle Scholar
  433. 432.
    Contribution à l’étude du role physiologique du glucagon. Bruxelles: S. A. Arscia 1966.Google Scholar
  434. 433.
    Lefebvre, P., et M. Beaujeau: Modifications circulatoires périphériques après administration de glucagon. Arch. int. Physiol. Biochem. 72, 9 (1964).Google Scholar
  435. 434.
    —, et H. v. Cauwenberge: Glucagon et réactions oedemateuses du rat. Arch. int. Pharmacodyn. 138, 222 (1962).PubMedGoogle Scholar
  436. 435.
    — —Où en est le problème du glucagon? Rev. franç. Étud. clin. biol. 8, 805 (1963).PubMedGoogle Scholar
  437. 436.
    — — Nouvelle recherches sur l’action eventuelle du glucagon sur l’utilisation périphérique du glucose. 5th Congr. Intern. Diabetes Feder. Toronto 1964.Google Scholar
  438. 437.
    — A. Cession-Fossion, and A. S. Luyckx: Glucagon test for phaeochromocytoma. Lancet 1966 II, 1366.Google Scholar
  439. 438.
    — — — J. Lecomte, and H. v. Cauwenberge: Interrelationships glucagonadrenergic system in experimental and clinical conditions. Intern. Symp. Pharmacol. Hormonal Polypept. Prot., Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  440. 439.
    —, et A. Dresse: Influence du glucagon sur le taux des catécholamines surrénaliénnes chez le rat. C. R. Soc. Biol. (Paris) 155, 412 (1961).Google Scholar
  441. 440.
    —, et F. Lebrun: Absence d’effet du glucagon sur la décroissance spontanée de la glycémie du sang humain in vitro. C. R. Soc. Biol. (Paris) 157, 675 (1963).Google Scholar
  442. 441.
    —, and P. Lelievre: Effects of glucagon on the metabolism of rat mitochondria. Arch. int. Physiol. Biochem. 72, 857 (1964).Google Scholar
  443. 442.
    —, et A. Luyckx: Modification par le foie isolé et perfusé de l’effet exercé par le glucagon sur la graisse épididymaire du rat. Ann. Endocr. (Paris) 26, 369 (1965).PubMedGoogle Scholar
  444. 443.
    — —Influence du glucagon sur le débit circulatoire pancréaticoduodénal et sur l’insulinémie du sang veineux pancréatique du chien. Arch. int. Physiol. Biochem. 74, 867 (1966).Google Scholar
  445. 444.
    — —Glucagon-stimulated insulin release. Lancet 1966 I, 1040.Google Scholar
  446. 445.
    — —Glucagon et metabolism du tissu adipeux. Journées Ann. Diabétol. Hôtel-Dieu, p. 67. Paris: Ed. Méd. Flammarion 1967.Google Scholar
  447. 446.
    Leibson, L.: The endocrine factors in the regulation of carbohydrate metabolism in the developing chick embryo. Biol. Neonat. (Basel) 9, 249 (1965/66).PubMedGoogle Scholar
  448. 447.
    Leonard, S. L., and M. Crandall: Hormonal stimulation of phosphorylase activity in the rat uterus in vitro. Endocrinology 73, 807 (1963).PubMedGoogle Scholar
  449. 448.
    Levarlet, M.: Action de l’adrénaline et du glucagon sur la glycémie, les lactates et les acides gras du plasma. C. R. Soc. Biol. (Paris) 156, 1940 (1962).Google Scholar
  450. 449.
    Levine, R.: Analysis of the actions of the hormonal antagonists of insulin. Diabetes 13, 362 (1964).PubMedGoogle Scholar
  451. 450.
    The action of insulin at the cell membrane. Amer. J. Med. 40, 691 (1966).PubMedGoogle Scholar
  452. 451.
    Levine, R. A.: Effect of glycogenolytic agents on phosphorylase activity of perfused rat liver. Amer. J. Physiol. 208, 317 (1965).PubMedGoogle Scholar
  453. 452.
    — L. A. Pesch, G. Klatskin, and N. J. Giarman: Effect of serotonin on glycogen metabolism in isolated rat liver. J. clin. Invest. 43, 797 (1964).PubMedGoogle Scholar
  454. 453.
    Lewis, G. M., J. Spencer-Peet, and K. M. Stewart: Infantile hypoglycaemia due to inherited deficiency of glycogen synthetase in liver. Arch. Dis. Childh. 38, 40 (1963).PubMedGoogle Scholar
  455. 454.
    Lin, K.: Effect of ligation of the pancreatic duct on the increase of plasma free fatty acid concentration after vagal stimulation. Sheng Li Hsueh Pao 27, 250 (1964). Chem. Abstr. 62, 10947 (1965).PubMedGoogle Scholar
  456. 455.
    Lin, T. M., D. N. Benslay, and R. H. Tust: Further study of the effect of glucagon on meal-histamine-gastrin-and sham feeding-induced gastric HC1 secretion. Physiologist 6, 225 (1963).Google Scholar
  457. 456.
    Lippmann, H. G., M. Klenke u. G. Mohnike: Glucagon als Synergist des Insulins. Naturwissenschaften 53, 309 (1966).PubMedGoogle Scholar
  458. 457.
    Liu, H. M., and E. L. Potter: Development of the human pancreas. Arch. Path. 74, 439 (1962).PubMedGoogle Scholar
  459. 458.
    Lochner, J. de V., A. M. Eisentraut, and R. H. Unger: The effects of CoCl2 on glucagon levels in plasma and pancreas of the rat. Metabolism 13, 868 (1964).Google Scholar
  460. 459.
    Lochner, J. de V., A. C. Esterhuizen, and R. H. Unger: Separation of human insulin, glucagon and other pancreatic proteins. Diabetes 13, 387 (1964).Google Scholar
  461. 460.
    Loeb, H., P. E. Grégoire, E. Rasiò et A. Cornil: L’hypoglycémie idiopathique infantile de McQuarrie. II. Physiopathologie de l’accès hypoglycémique. Helv. paediat. Acta 19, 304 (1964).PubMedGoogle Scholar
  462. 461.
    Löffler, G., H. Geerling u. K. F. Weinges: Der Glucosestoffwechsel des isolierten Fettgewebes bei Lipogenese und Lipolyse. Verh. dtsch. Ges. inn. Med. 71, 470 (1965).Google Scholar
  463. 462.
    — K. F. Weinges u. H. Kettl: Mechanismen lipolytischer Vorgänge im Fettgewebe. I. Mitt. Vergleichende Untersuchungen über die hormonelle Beeinflussung der Lipase und Phosphorylase in vitro. Klin. Wschr. 44, 1085 (1966).Google Scholar
  464. 463.
    Logothetopoulos, J.: Electron microscopy of the pancreatic islets of the rat. Effects of prolonged insulin injections. Diabetes 15, 823 (1966).PubMedGoogle Scholar
  465. 464.
    Lohmann, D., u. A. Bock: Die Wirkung des Glucagons auf den Blutzuckerspiegel in Abhängigkeit vom Alter. Z. Alternsforsch. 16, 206 (1963).Google Scholar
  466. 465.
    Loubatières, A., M. M. Mariani, A. M. Rondot et J. Chapal: Présence et repartition de l’adrénaline et de la noradrénaline dans le pancréas du chien. C. R. Soc. Biol. (Paris) 158, 607 (1964).Google Scholar
  467. 466.
    Love, W. C., L. Carr, and J. Ashmore: Influence of isoproterenol and 1-(2′,4′-dichlorophenyl)-2-t-butylaminoethanol (DCB) on free fatty acid release and glucose metabolism in adipose tissue. J. Pharmacol. exp. Ther. 142, 137 (1963).PubMedGoogle Scholar
  468. 467.
    Lowe, C. U., J. E. Sokal, L. L. Mosovich, E. J. Sarcione, and B. H. Doray: Studies in liver glycogen disease. Effects of glucoagon and other agents on metabolic pattern and clinical status. Amer. J. Med. 33, 4 (1962).PubMedGoogle Scholar
  469. 468.
    Lupulescou, A., E. Merculiev, C. Neascou et C. Petrescou: L’action du glucagon et de l’insuline sur la fonction de la glande thyroïde. Acta biol. med. germ. 15, 30 (1965).Google Scholar
  470. 469.
    — V. Chivu, and A. Petrovici: Effect of aldosterone, glucagon and growth hormone on the catechol amine content and the evolution of chromaffin hyperplasia in guinea pigs. Experientia (Basel) 22, 222 (1966).Google Scholar
  471. 470.
    — — —Effect of aldosterone, glucagon, and somatotropic hormones on the adrenal medulla in guinea pigs. Rev. Roum. Endocr. 4, 23 (1967).Google Scholar
  472. 471.
    Lyon, J. B., J. Porter, and M. Robertson: Phosphorylase b kinase inheritance in mice. Science 155, 1550 (1967).PubMedGoogle Scholar
  473. 472.
    MacDonald, S. J., K. O. DeBoer, and B. de Boer: Carbohydrate and protein metabolism in rats during chronic administration of glucagon and epinephrine. Proc. Soc. exp. Biol. (N. Y.) 119, 1221 (1965).PubMedGoogle Scholar
  474. 473.
    Maddaiah, V. T., and N. B. Madsen: Studies on the biological control of glycogen metabolism in liver. I. State and activity pattern of glycogen phosphorylase. Biochim. biophys. Acta (Amst.) 121, 261 (1966).PubMedGoogle Scholar
  475. 474.
    — —Kinetics of purified liver phosphorylase. J. biol. Chem. 241, 3873 (1966).PubMedGoogle Scholar
  476. 475.
    Madison, L. L., D. Mebane, R. H. Unger, and A. Lochner: The hypoglycemic action of ketones. II. Evidence for a stimulatory feedback of ketones on the pancreatic beta cells. J. clin. Invest. 43, 408 (1964).PubMedGoogle Scholar
  477. 476.
    Madsen, N. B. The occurrence and enzymatic synthesis of glycogen in extracts of agrobacterium tumefaciens. Biochem. biophys. Res. Commun. 6, 194 (1961).Google Scholar
  478. 477.
    The inhibition of glycogen phosphorylase by uridine diphosphate glucose. Biochem. biophys. Res. Commun. 6, 310 (1961).PubMedGoogle Scholar
  479. 478.
    —, and S. Shechosky: Allosteric properties of phosphorylase b. II. Comparison with a kinetic model. J. biol. Chem. 242, 3301 (1967).PubMedGoogle Scholar
  480. 479.
    Mahler, R., W. S. Stafford, M. E. Tarrant, and J. Ashmore: The effect of insulin on lipolysis. Diabetes 13, 297 (1964).PubMedGoogle Scholar
  481. 480.
    Makman, M. H., and E. W. Sutherland jr.: Use of liver adenyl cyclase for assay of glucagon in human gastrointestinal tract and pancreas. Endocrinology 75, 127 (1964).PubMedGoogle Scholar
  482. 481.
    Malaisse, W. J., F. Malaisse-Lagae, D. A. Mayhew, P. H. Wright, and J. Ashmore: Hormonal regulation of insulin secretion. Clin. Res. 15, 325 (1967).Google Scholar
  483. 482.
    — —, and P. H. Wright: The effect of fasting upon insulin secretion in the rat. Fed. Proc. 26, 317 (1967).Google Scholar
  484. 483.
    — — —, and J. Ashmore: Effects of adrenergic and cholinergic agents upon insulin secretion in vitro. Endocrinology 80, 975 (1967).PubMedGoogle Scholar
  485. 484.
    Malandra, B.: Sulla sarcoidosi ossea. Riv. Anat. pat. 12, 26 (1957).Google Scholar
  486. 485.
    Mallette, L. E., J. H. Exton, and C. R. Park: Glucagon stimulation of amino acid gluconeogenesis. Fed. Proc. 26, 563 (1967).Google Scholar
  487. 486.
    Mann III, J. T., and S. B. Tove: Purification and properties of a lipase from rat adipose tissue. J. biol. Chem. 241, 3595 (1966).PubMedGoogle Scholar
  488. 487.
    Mansour, T. E.: Effect of hormones on carbohydrate metabolism of invertebrates. Fed. Proc. (Symp.) 26, 1179 (1967).PubMedGoogle Scholar
  489. 488.
    — N. A. LeRouge, and J. M. Mansour: Activation of phosphofructokinase from the liver fluke Fasciola hepatica by serotonin and cyclic 3′,5′-AMP. Biochem. Pharmacol. 9, 149 (1962).Google Scholar
  490. 489.
    Marks, V.: Response to glucagon by subjects with hyperinsulinism from islet-cell tumors. Brit. med. J. 1960 I, 1539.Google Scholar
  491. 490.
    —, and E. Samols: Hypoglycaemia of non-endocrine origin (non-islet cell tumours). Proc. royal Soc. Med. 59, 338 (1966).Google Scholar
  492. 491.
    Marri, G., e G. Cozzolino: Stimolazione della secrezione insulinica nell’uomo mediante infusione di glucagone. Boll. Soc. ital. Biol. sper. 42, 1422 (1966).PubMedGoogle Scholar
  493. 492.
    — J. Tyler, V. Marks e E. Samols: Stimolazione della secrezione insulinica nell’uomo mediante glucagone. Minerva med. 57, 2733 (1966).PubMedGoogle Scholar
  494. 493.
    Marsh, J. M., R. W. Butcher, K. Savard, and E. W. Sutherland: The stimulatory effect of luteinizing hormone on adenosine 3′,5′-monophosphate accumulation in corpus luteum slices. J. biol. Chem. 241, 5436 (1966).PubMedGoogle Scholar
  495. 494.
    —, and K. Savard: The activation of luteal phosphorylase by luteinizing hormone. J. biol. Chem. 239, 1 (1964).PubMedGoogle Scholar
  496. 495.
    Martini, V., M. Orunescu e E. Fugassa: Diminuzione della polisaccaride fosforilasi epatica nell’ipertiroidismo da triiodotironina. Arch. Sci. biol. (Bologna) 48, 94 (1964).Google Scholar
  497. 496.
    Martz, G., u. A. Labhart: Glukagon. Schweiz. med. Wschr. 86, 57 (1956).PubMedGoogle Scholar
  498. 497.
    Masken, J. F., R. P. Martin, and M. L. Hopwood: Effect of insulin and hexokinase on glycolysis of bovine spermatozoa. J. Dairy Sci. 47, 1257 (1964).Google Scholar
  499. 498.
    — — —Influence of glucagon on bovine sperm glycolysis. J. Dairy Sci. 48, 493 (1965).PubMedGoogle Scholar
  500. 499.
    Matsushima, A., Y. Inada, and K. Shibata: States of amino acid residues in protein. X. Tyrosine residues in oxytocin and glucagon. Biochim. biophys. Acta (Amst.) 121, 338 (1966).PubMedGoogle Scholar
  501. 500.
    Mayer, J.: Some aspects of the problem of regulation of food intake and obesity. New Engl. J. Med. 274, 610, 662, 722 (1966).PubMedGoogle Scholar
  502. 501.
    —, and D. W. Thomas: Regulation of food intake and obesity. Science 156, 328 (1967).PubMedGoogle Scholar
  503. 502.
    Mayer, S. E.: Action of epinephrine on glucose uptake and glucose-6-phosphate in the dog heart in situ. Biochem. Pharmacol. 12, 193 (1963).PubMedGoogle Scholar
  504. 503.
    Mayo, H. W. jr., and D. M. Enerson: Endocrine influences of the pancreas on gastric secretion. I. The effects of glucagon and alloxan on Heidenhain pouch secretion. Surgery 44, 91 (1958).PubMedGoogle Scholar
  505. 504.
    McGavran, M. H., R. H. Unger, L. Recant, H. C. Polk, C. Kilo, and M. E. Levin: A glucagon-secreting alpha-cell carcinoma of the pancreas. New Engl. J. Med. 274, 1408 (1966).PubMedGoogle Scholar
  506. 505.
    McIntyre, N., C. D. Holdsworth, and D. S. Turner: Intestinal factors in the control of insulin secretion. J. clin. Endocrinol. 25, 1317 (1965).Google Scholar
  507. 506.
    McLean, P., and J. Brown: Some properties of rat liver glucose-adenosine triphosphate phosphotransferases. Biochem. J. 100, 793 (1966).PubMedGoogle Scholar
  508. 507.
    —, and F. Novello: Influence of pancreatic hormones on enzymes concerned with urea synthesis in rat liver. Biochem. J. 94, 410 (1965).PubMedGoogle Scholar
  509. 508.
    McQuarrie, J.: Idiopathic spontaneously occurring hypoglycemia in infants. Amer. J. Dis. Child. 87, 399 (1954).Google Scholar
  510. 509.
    Mebane, D., and L. L. Madison: Clinical and experimental hypoglycemic action of ketones. I. Effects of ketones on hepatic glucose output and peripheral glucose utilization. J. Lab. clin. Med. 63, 177 (1964).PubMedGoogle Scholar
  511. 510.
    Mehnert, H., G. Schäfer, G. Kaliampetsos, K. Stuhlfauth u. W. Engelhardt: Die Insulinsekretion des Pankreas bei extracorporaler Perfusion. II. Mitt. Durchströmungen der Bauchspeicheldrüse mit Periston, Glucose, Carbutamid und Biguaniden. Klin. Wschr. 40, 1146 (1962).PubMedGoogle Scholar
  512. 511.
    Melichar, V., M. Novák, J. Zoula, P. Hahn, and O. Koldovský: Energy sources in the newborn. Biol. Neonat. (Basel) 9, 298 (1965–66).PubMedGoogle Scholar
  513. 512.
    Merimee, T. J., and T. E. Prout: Studies of glucagon I131 in normal and immune serum. J. Lab. clin. Med. 64, 412 (1964).PubMedGoogle Scholar
  514. 513.
    Mertz, D. P.: Über den diuretischen und saluretischen Effekt von Glucagon beim Menschen. Z. ges. exp. Med. 136, 331 (1963).PubMedGoogle Scholar
  515. 514.
    Metz, R., and J. M. Salter: Effect of glucagon on liver glycolysis. Nature (Lond.) 196, 1094 (1962).PubMedGoogle Scholar
  516. 515.
    Meyer, J., and S. A. Bencosme: The fine structure of normal rabbit pancreatic islet cells. Rev. canad. Biol. 24, 179 (1965).PubMedGoogle Scholar
  517. 516.
    Meyer, W. L., E. H. Fischer, and E. G. Krebs: Activation of skeletal muscle phosphorylase b kinase by CA2+. Biochemistry 3, 1033 (1964).PubMedGoogle Scholar
  518. 517.
    Mialhe, P.: Glucagon, insuline et régulation endocrine de la glycémie chez le canard. Acta endocr. (Kbh.) 28, Suppl. 36 (1958).Google Scholar
  519. 518.
    B. C. J. Sutter et V. Meyer: L’adrénaline, inhibiteur de l’insuline sérique chez le rat. Diabetologia 1, 63 (1965).Google Scholar
  520. 519.
    Mier, P. D., and D. W. K. Cotton: Enzymes of the glycolytic pathway in skin. III. Phosphorylase. Brit. J. Derm. 79, 164 (1967).PubMedGoogle Scholar
  521. 520.
    Mikami, S.-I., and K. Ono: Glucagon deficiency induced by extirpation of alpha islets of the fowl pancreas. Endocrinology 71, 464 (1962).PubMedGoogle Scholar
  522. 521.
    Miller, L. L.: Glucagon: a protein catabolic hormone in the isolated perfused rat liver. Nature (Lond.) 185, 248 (1960).PubMedGoogle Scholar
  523. 522.
    Direct actions of insulin, glucagon and epinephrine on the isolated perfused rat liver. Fed. Proc. 24, 737 (1965).PubMedGoogle Scholar
  524. 523.
    — Effects of glucagon on carbohydrate and protein metabolism in perfused rat liver. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  525. 524.
    Miller, M. R., and D. H. Wurster: The morphology and physiology of the pancreatic islets in urodele amphibians and lizards. In: A. Gorbman (ed.), Comparative endocrinology, p. 668. New York: J. Wiley & Sons 1959.Google Scholar
  526. 525.
    Miller, W. L., and J. J. Krake: Comparative expiratory and oxidative effects of glucagon and epinephrine in mice. Proc. Soc. exp. Biol. (N. Y.) 113, 784 (1963).Google Scholar
  527. 526.
    Milner, R. D. G., and C. N. Hales: The sodium pump and insulin secretion. Biochim. biophys. Acta (Amst.) 135, 375 (1967).PubMedGoogle Scholar
  528. 527.
    —, and A. D. Wright: Plasma glucose, nonesterified fatty acid, insulin and growth hormone response to glucagon in the newborn. Clin. Sci. 32, 249 (1967).PubMedGoogle Scholar
  529. 528.
    Mintz, D. H., J. Finster, and M. Stept: Effect of angiotensin II on immunoreactive insulin. J. clin. Endocr. 27, 671 (1967).PubMedGoogle Scholar
  530. 529.
    Moore, R. O.: Influence of fasting and re-feeding on response of adipose tissue to insulin. Amer. J. Physiol. 205, 222 (1963).PubMedGoogle Scholar
  531. 530.
    Morgan, C. R., A.-M. Carpenter, and A. Lazarow: Effect of insulin antibodies on pancreatic islet insulin and beta cell granule content. Anat. Rec. 153, 49 (1965).PubMedGoogle Scholar
  532. 531.
    Morgan, H. E., and A. Parmeggiani: Regulation of glycogenolysis in muscle. Effect of glucagon and anoxia on glycogenolysis in the perfused rat heart; effect of adenine nucleotides, glucose 6-phosphate and inorganic phosphate on muscle phosphorylase activity. In: W. J. Whelan, and M. P. Cameron (eds.), Control of glycogen metabolism, p. 254. Boston: Little, Brown & Co. 1964.Google Scholar
  533. 532.
    — —Regulation of glycogenolysis in muscle. II. Control of glycogen phosphorylase reaction in isolated perfused heart. J. biol. Chem. 239, 2435 (1964).PubMedGoogle Scholar
  534. 533.
    Morris, T. Q., G. F. Sardi, and S. E. Bradley: Character of glucagon induced choleresis. Fed. Proc. 26, 774 (1967).Google Scholar
  535. 534.
    Moss, J.M.: Hypoglycemia due to excessive insulin. G P (Chic.) 26, 123 (1962).Google Scholar
  536. 535.
    Mulligan, P. B., and R. Schwartz: Hepatic carbohydrate metabolism in the genesis of neonatal hypoglycemia. Effects of the administration of epinephrine, glucagon and galactose. Pediatrics 30, 125 (1962).PubMedGoogle Scholar
  537. 536.
    Munger, B. L.: The secretory cycle of the pancreatic islet α-cell. An electron microscopic study of normal and synthalin-treated rabbits. Lab. Invest. 11, 885 (1962).PubMedGoogle Scholar
  538. 537.
    — Histochemistry and ultrastructure of the alpha cell. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  539. 538.
    Murad, F., Y.-M. Chi, T. W. Rall, and E. W. Sutherland: Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3′,5′-phosphate by preparations from cardiac muscle and liver. J. biol. Chem. 237, 1233 (1962).PubMedGoogle Scholar
  540. 539.
    Mutt, V., and J. E. Jorpes: Contemporary developments in the biochemistry of the gastrointestinal hormones. Recent Progr. Hormone Res. 23, 483 (1967).PubMedGoogle Scholar
  541. 540.
    S. Magnusson, J. E. Jorpes, and E. Dahl: Structure of porcine secretin. I. Degradation with trypsin and thrombin. Sequence of the tryptic peptides. The C-terminal residue. Biochemistry 4, 2358 (1965).Google Scholar
  542. 541.
    Nair, K. G.: Purification and properties of 3′,5′-cyclic nucleotide phosphodiesterase from dog heart. Biochemistry 5, 150 (1966).PubMedGoogle Scholar
  543. 542.
    Nakano, S.: Studies on the physiological action of glucagon, with special reference to its relation with adrenalin and insulin. Tokyo Jikei Med. Sch. J. 73, 1118 (1957).Google Scholar
  544. 543.
    Natelson, S., J. B. Pincus, and G. Rannazzisi: Dynamic control of calcium, phosphate, citrate, and glucose levels in blood serum. Effect of ACTH, adrenaline, noradrenaline, hydrocortisone, parathormone, insulin and glucagon. Clin. Chem. 9, 31 (1963).PubMedGoogle Scholar
  545. 544.
    Necheles, H., J. Sporn, and L. Walker: Effect of glucagon on gastrointestinal motility. Amer. J. Gastroent. 45, 34 (1966).PubMedGoogle Scholar
  546. 545.
    Nelson, D., and C. E. Jensen: Blood alcohol disappearance rate after the administration of I.V. glucagon. Fed. Proc. 20, 189 (1961).Google Scholar
  547. 546.
    Nelson, J. K., D. Rabinowitz, and T. J. Merimee: The effect of epinephrine on insulin release in man induced by secretin. Nature (Lond.) 215, 883 (1962).Google Scholar
  548. 547.
    Nicola, P., E. Zoratto e S. Baratono: Azione del glucagone sulla glicemia nelle varie età infantili. Minerva pediat. 17, 1598 (1965).PubMedGoogle Scholar
  549. 548.
    — — —Interferenza del cortisone sulla risposta iperglicemica al glucagone nel bambino. Minerva pediat. 17, 1603 (1965).PubMedGoogle Scholar
  550. 549.
    Niemeyer, H., L. Clark-Turri, and E. Rabajille: Induction of glucokinase by glucose in rat liver. Nature (Lond.) 198, 1096 (1963).PubMedGoogle Scholar
  551. 550.
    N. Pérez, and R. Codoceo: Liver glucokinase induction in acute and chronic insulin insufficiency in rats. J. biol. Chem. 242, 860 (1967).PubMedGoogle Scholar
  552. 551.
    — —, and E. Rabajille: Interrelation of actions of glucose, insulin, and glucagon on induction of adenosine triphosphate: D-hexose phosphotransferase in rat liver. J. biol. Chem. 241, 4055 (1966).PubMedGoogle Scholar
  553. 552.
    Nishikawara, M. T.: Hepatic glutamic dehydrogenase in diabetes and following excess glucagon. Endocrinology 79, 997 (1966).PubMedGoogle Scholar
  554. 553.
    Nitzan, M., and A. Kowadlo-Silbergeld: Responses to glucagon and epinephrine and glycogen reserves in children with nondiabetic ketosis. Israel J. med. Sci. 2, 683 (1966).PubMedGoogle Scholar
  555. 554.
    Nolan, C., W. B. Novoa, E. G. Krebs, and E. H. Fischer: Further studies on the site phosphorylated in the phosphorylase b to a reaction. Biochemistry 3, 542 (1964).PubMedGoogle Scholar
  556. 555.
    Nordlie, R. C., and D. G. Lyger: The inhibition by citrate of inorganic pyrophosphate-glucose phosphotransferase and glucose 6-phosphatase. J. biol. Chem. 241, 3136 (1966).PubMedGoogle Scholar
  557. 556.
    Northrop, G., and R. E. Parks jr.: 3′,5′-AMP-induced hyperglycemia in intact rats and in the isolated perfused rat liver. Biochem. Pharmacol. 13, 120 (1964).PubMedGoogle Scholar
  558. 557.
    — —Studies on epinephrine and 3′,5′-AMP induced hyperglycemia employing the isolated perfused rat liver preparation. J. Pharmacol. exp. Ther. 145, 135 (1964).PubMedGoogle Scholar
  559. 558.
    Öckerman, P. A., H. Jelke, and K. Kaijser: Glycogenosis Type 6 (Liver phosphorylase deficiency). A case followed for ten years, with normal phosphorylase activity in white blood cells and jejunal mucosa. Acta paediat. (Uppsala) 55, 10 (1966).Google Scholar
  560. 559.
    Oh, W., G. S. Baens, C. J. Migeon, S. H. Wybregt, and M. Cornblath: Studies of carbohydrate metabolism in the newborn infant. V. The effect of cortisol on the hyperglycemic response to glucagon. Pediatrics 30, 769 (1962).Google Scholar
  561. 560.
    Ohneda, A., H. Ketterer, A. M. Eisentraut, and R. H. Unger: Effect of glucose and of amino acids on glucagon secretion. Clin. Res. 15, 62 (1967).Google Scholar
  562. 561.
    Okuda, T., and A. Grollman: Action of neutral red on the secretion of glucagon and glucose metabolism in the rat. Endocrinology 78, 195 (1966).PubMedGoogle Scholar
  563. 562.
    Okuno, G.: Recent progress in glucagon research. Saishinigaku 21, 153 (1966).Google Scholar
  564. 563.
    —, and P. P. Foà: Development of hepatic phosphorylase in the chick embryo. Proc. Soc. exp. Biol. (N. Y.) 117, 524 (1964).PubMedGoogle Scholar
  565. 564.
    —, and M. Nishikawa: Activities of glycogen synthetase and UDPG-pyrophosphorylase in muscle of a patient with a new type of muscle glycogenosis caused by phosphofructokinase deficiency. Nature (Lond.) 212, 1490 (1966).PubMedGoogle Scholar
  566. 565.
    —, and K. Kuroda: Effects of glucagon on lipid metabolism. I. 14C-glucose incorporation into lipid of rat adipose tissue in vitro. Ann. Meet. Endocr. Soc. Japan 1966.Google Scholar
  567. 566.
    —, and P. P. Foà: Development of phosphorylase and of phosphorylase-activating (glucagon-like) substances in the rat embryo. Gen. comp. Endocr. 4, 446 (1964).Google Scholar
  568. 567.
    Ontko, J. A., and D. B. Zilversmit: Correlation between concentrations of circulating free fatty acids and ketone bodies. Proc. Soc. exp. Biol. (N. Y.) 121, 319 (1966).PubMedGoogle Scholar
  569. 568.
    Orloff, J., and J. S. Handler: The effect of adenosine 3′,5′-phosphate (cyclic AMP), theophylline, and vasopressine on water movement and sodium transport in the toad bladder. In: P.C. Williams (ed.), Hormones and the kidney, p. 89. New York: Academic Press 1963.Google Scholar
  570. 569.
    —, and J. Handler: The role of adenosine 3′,5′-phosphate in the action of anti-diuretic hormone. Amer. J. Med. 42, 757 (1967).PubMedGoogle Scholar
  571. 570.
    Øye, I.: The role of phosphorylase a and b for the control of glycogenolysis in the isolated working rat heart. Acta physiol. scand. 70, 229 (1967).Google Scholar
  572. 571.
    Özand, P., and H. T. Narahara: Regulation of glycolysis in muscle. III. Influence of insulin, epinephrine and contraction on phosphofructokinase activity in frog skeletal muscle. J. biol. Chem. 239, 3146 (1964).Google Scholar
  573. 572.
    Paloyan, E.: Recent developments in the early diagnosis of hyperparathyroidism. Surg. Clin. N. Amer. 47, 61 (1967).PubMedGoogle Scholar
  574. 573.
    — The forms of pancreatitis. In press.Google Scholar
  575. 574.
    — A. M. Lawrence, F. H. Straus II, D. Paloyan, P. V. Harper, and D. Cummings: Alpha cell hyperplasia in calcific pancreatitis associated with hyperparathyroidism. J. Amer. med. Ass. 200, 757 (1967).Google Scholar
  576. 575.
    Paloyan, E., D. Paloyan, and P. V. Harper: Glucagon-induced hypocalcemia. Metabolism 16, 35 (1967).PubMedGoogle Scholar
  577. 576.
    — — —The role of glucagon hypersecretion in the relationship of pancreatitis and hyperparathyroidism. Surgery 62, 167 (1967).Google Scholar
  578. 577.
    Pantzer, J. G., and H. B. Shumacher jr.: Coronary sinus flow. Influence of glucagon and hypertonic dextrose and saline. Arch. Surg. 85, 879 (1962).PubMedGoogle Scholar
  579. 578.
    Park, C. R.: Control of hepatic 3′,5′-cyclic adenylate. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  580. 579.
    — Mode of action of insulin. Panel discussion. Sixth Congr. Intern. Diabetes Feder., Excerpta Med., I. C. S. (in press).Google Scholar
  581. 580.
    Parmeggiani, A., and R. H. Bowman: Regulation of phosphofructokinase activity by citrate in normal and diabetic muscle. Biochem. biophys. Res. Commun. 12, 268 (1963).PubMedGoogle Scholar
  582. 581.
    Passonneau, J. V., and O. H. Lowry: The role of phosphofructokinase in metabolic regulation. Advanc. Enzyme Regul. 2, 265 (1964).Google Scholar
  583. 582.
    Penhos, J. C., B. A. Houssay, and M. A. Luján: Total pancreatectomy in lizards. Effects of several hormones. Endocrinology 76, 989 (1965).PubMedGoogle Scholar
  584. 583.
    —, and N. Lavintman: Total pancreatectomy in toads: effect of hypophysectomy and glucagon. Gen. comp. Endocr. 4, 264 (1964).Google Scholar
  585. 584.
    —, and B. Uno: Hormonal factors in glucose uptake by the toad’s isolated heart. Acta physiol. lat.-amer. 14, 392 (1964).PubMedGoogle Scholar
  586. 585.
    —, and R. Levine: Effect on insulin on the metabolism of lipids and on urea formation by the perfused rat liver. Fed. Proc. 26, 774 (1967).Google Scholar
  587. 586.
    — —, and R. Levine: Effect of glucagon on the metabolism of lipids and on urea formation by the perfused rat liver. Diabetes 15, 740 (1966).PubMedGoogle Scholar
  588. 587.
    — —, and R. Levine: Effects of several hormones after total pancreatectomy in alligators. Gen. comp. Endocr. 8, 32 (1967).Google Scholar
  589. 588.
    Penick, S. B., and L. E. Hinkle jr.: Depression of food intake induced in healthy subjects by glucagon. New Engl. J. Med. 264, 893 (1961).PubMedGoogle Scholar
  590. 589.
    —, and L. E. Hinkle jr.: Fall in plasma content of free fatty acids associated with sight of food. New England J. Med. 275, 416 (1966).Google Scholar
  591. 590.
    —, and G. P. Smith: The effect of glucagon on food intake and body weight in man. J. Obesity 1, 1 (1964).Google Scholar
  592. 591.
    Perassi, N. I.: Effectos del glucagon e insulina sobre captación y liberación de glucosa por el higado de Bufo ArenarumHensel. Rev. Soc. argent. Biol. 36, 464 (1960).PubMedGoogle Scholar
  593. 592.
    Action du glucagon ou de l’insuline sur la libération ou la captation de glucose par le foie de crapaud. C. R. Soc. Biol. (Paris) 155, 406 (1961).Google Scholar
  594. 593.
    Pérez, N., L. Clark-Turri, E. Rabajille and H. Niemeyer: Regulation of rat liver enzymes by natural components of the diet. J. biol. Chem. 239, 2420 (1964).PubMedGoogle Scholar
  595. 594.
    Perkoff, G. T., V. J. Parker, and P. F. Hahn: The effects of glucagon on three forms of glycogen storage disease. J. clin. Invest. 41, 1099 (1962).PubMedGoogle Scholar
  596. 595.
    Perley, M., and D. M. Kipnis: Effect of glucocorticoids on plasma insulin. New Engl. J. Med. 274, 1237 (1966).PubMedGoogle Scholar
  597. 596.
    Peterson, R. D., C. H. Beatty, and R. M. Bocek: Effects of insulin and glucagon on carbohydrate and protein metabolism of adductor muscle and diaphragm. Endocrinology 72, 71 (1963).PubMedGoogle Scholar
  598. 597.
    Petersson, B.: Isolation and characterization of different types of pancreatic islet cells in guinea pigs. Acta endocr. (Kbh.) 53, 480 (1966).PubMedGoogle Scholar
  599. 598.
    Cytochemical studies of hydrolytic and oxidative enzymes in sections and isolated cells from the endocrine pancreas of guinea pigs. Histochemie 7, 116 (1966).PubMedGoogle Scholar
  600. 599.
    The two types of alpha cells during the development of the guinea pig pancreas. Z. Zellforsch. 75, 371 (1966).PubMedGoogle Scholar
  601. 600.
    Petersson, B.: Studies on the islets of Langerhans in guinea pigs with special reference to the two types of A cells. Acta Univ. upsalien. 37 (1966).Google Scholar
  602. 601.
    —, and B. Hellman: Effects of long term administration of glucagon on the pancreatic islet tissue of rats and guinea pigs. Acta endocr. (Kbh.) 44, 139 (1963).PubMedGoogle Scholar
  603. 602.
    Petkov, P. E.: Histochemical differences in the endocrine pancreas of several mammals. Ann. Histochim. 11, 79 (1966).PubMedGoogle Scholar
  604. 603.
    Pfeiffer, E. F., M. Telib, J. Ammon, F. Melani u. H. Ditschuneit: Direkte Stimulierung der Insulin-Sekretion in vitro durch Sekretin. Dtsch. med. Wschr. 90, 1663 (1965).PubMedGoogle Scholar
  605. 604.
    Phillips, M. J., N. J. Unakar, G. Doornewaard, and J. W. Steiner: Glycogen depletion in the newborn rat liver. An electron microscopic and electron histochemical study. J. Ultrastruct. Res. 18, 142 (1967).PubMedGoogle Scholar
  606. 605.
    Picon-Reategui, E.: Insulin, epinephrine, and glucagon on the metabolism of carbohydrates at high altitudes. Fed. Proc. (Symp.) 25, 1233 (1966).PubMedGoogle Scholar
  607. 606.
    Pitot, H.C., C. Peraino, N. Pries, and A.L. Kennan: Glucose repression and induction of enzyme synthesis in rat liver. Advanc. Enzyme Regul. 2, 237 (1964).Google Scholar
  608. 607.
    Planas, J., and F. Garcia: New data regarding the pancreatic islets of the tunny-fish. Acta anat. (Basel) 57, 185 (1964).PubMedGoogle Scholar
  609. 608.
    Pogson, C. I., and P. J. Randle: The control of rat heart phosphofructokinase by citrate and other regulators. Biochem. J. 100, 683 (1966).PubMedGoogle Scholar
  610. 609.
    Porte, D. jr.: A receptor mechanism of the inhibition of insulin release by epinephrine in man. J. clin. Invest. 46, 86 (1967).PubMedGoogle Scholar
  611. 610.
    A. L. Graber, T. Kuzuya, and R. H. Williams: The effect of epinephrine on immunoreactive insulin levels in man. J. clin. Invest. 45, 228 (1966).PubMedGoogle Scholar
  612. 611.
    —, and R. H. Williams: Inhibition of insulin relase by norepinephrine in man. Science 152, 1248 (1966).PubMedGoogle Scholar
  613. 612.
    Potter, V. R., and T. Ono: Enzyme patterns in rat liver and Morris hepatoma 5123 during metabolic transitions. Cold. Spr. Harb. Symp. quant. Biol. 26, 355 (1961).Google Scholar
  614. 613.
    Probst, G. W., and R. W. Colwell: Glucagon immunoassay by tracer displacement. Biochemistry 5, 1209 (1966).PubMedGoogle Scholar
  615. 614.
    Pullman, T. N., A. R. Lavender, and I. Aho: Direct effects of glucagon on renal hemodynamics and excretion of inorganic ions. Metabolism 16, 358 (1967).PubMedGoogle Scholar
  616. 615.
    Quirarte, C., E. R. Woodward, and L. R. Dragstedt: Glucagon and inhibition of gastric secretion. Arch. Surg. 93, 475 (1966).PubMedGoogle Scholar
  617. 616.
    Raben, M. S., and F. Matsuzaki: Effect of purines on epinephrine-induced lipolysis in adipose tissue. J. biol. Chem. 241, 4781 (1966).PubMedGoogle Scholar
  618. 617.
    Rabinowitz, D., G. A. Klassen, and K. L. Zierler: Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J. clin. Invest. 44, 51 (1965).PubMedGoogle Scholar
  619. 618.
    —, and K. L. Zierler: A metabolic regulating device based on the action of human growth hormone and of insulin, singly and together, on the human forearm. Nature (Lond.) 199, 913 (1963).PubMedGoogle Scholar
  620. 619.
    Rajarama Rao, M. R., and N. N. De: The influence of hyperglycemic glycogenolytic factor (HGF) on glycogenolysis in skin. Acta endocr. (Kbh.) 18, 299 (1955).Google Scholar
  621. 620.
    Rall, T. W., and S. Kakiuchi: The influence of neurohormones on the level of adenosine 3′, 5′-phosphate (3, 5-AMP) in brain tissue. 150th Meet. Amer. Chemical Society, Atlantic City, N. J., September 13–17 (1965).Google Scholar
  622. 621.
    —, and E. W. Sutherland: The regulatory role of adenosine-3′,5′-phosphate. In: Cell regulatory mechanisms. Cold Spr. Harb. Symp. quant. Biol. 26, 347 (1961).Google Scholar
  623. 622.
    — —Enzymes concerned with interconversion of liver phosphorylases. In: S. P. Colowick and N. O. Kaplan (eds.), Methods in enzymology, vol. 5., p. 377. New York: Academic Press 1962.Google Scholar
  624. 623.
    — —Adenyl cyclase. II. The enzymatically catalyzed formation of adenosine 3′,5′-phosphate and inorganic pyrophosphate from adenosine triphosphate. J. biol. Chem. 237, 1228 (1962).PubMedGoogle Scholar
  625. 624.
    Randle, P. J.: The interrelations of hormones, fatty acid, and glucose in the provision of energy. Postgrad. med. J. 40, 457 (1964).PubMedGoogle Scholar
  626. 625.
    — P. B. Garland, C. N. Hales, and E. A. Newsholme: The glucose fatty acid cycle and diabetes mellitus. Ciba Found. Coll. Endocr. 15, 192 (1964).Google Scholar
  627. 626.
    — — — — R. M. Denton, and C. I. Pogson: Interactions of metabolism and the physiological role of insulin. Recent Progr. Hormone Res. 22, 1 (1966).PubMedGoogle Scholar
  628. 627.
    — — E. A. Newsholme, and C. N. Hales: The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann. N.Y. Acad. Sci. 131, 324 (1965).PubMedGoogle Scholar
  629. 628.
    Rangnekar, P. V., and P. B. Sabnis: Blood sugar responses to glucagon and insulin administration in the frog, Rana tigrina, and the lizard, Varanus monitor. J. Animal Morph. Physiol. 11, 173 (1964).Google Scholar
  630. 629.
    Rathgeb, I., N. Altszuler, R. Steele, and R. C. de Bodo: Effect of glucagon infusion on glucose uptake and insulin secretion in normal dogs. Fed. Proc. 25, 378 (1966).Google Scholar
  631. 630.
    Recant, L.: Clinical Hyperglucagonism. Res. Symp. on Glucagon, San Francisco, October 7–8, 1966.Google Scholar
  632. 631.
    Reeves, R. B.: Phosphorylase activity and glycogenolysis in the working turtle heart. Amer. J. Physiol. 206, 898 (1964).PubMedGoogle Scholar
  633. 632.
    Regan, T. J., P. H. Lehan, D. H. Henneman, A. Behar, and H. K. Hellems: Myocardial metabolic and contractile response to glucagon and epinephrine. J. Lab. clin. Med. 63, 638 (1964).PubMedGoogle Scholar
  634. 633.
    Regen, D. M.: Personal communication.Google Scholar
  635. 634.
    — W. W. Davis, H. E. Morgan, and C. R. Park: The regulation of hexokinase and phosphofructokinase activity in heart muscle. Effects of alloxan diabetes, growth hormone, cortisol, and anoxia. J. biol. Chem. 239, 43 (1964).PubMedGoogle Scholar
  636. 635.
    Reis, L. C. F., e F. L. Vichi: Estudos sôbre o metabolismo dos hidratos de carbono na molestia de Chagas. II. A prova de glucagon. Rev. Ass. méd. bras. 11, 61 (1965).PubMedGoogle Scholar
  637. 636.
    Relander, A., and C.-E. Raiha: Effect of insulin and glucagon on the stroma bound hexoses in erythrocytes. 5th Cong. Intern. Diabetes Federation, Toronto 1964.Google Scholar
  638. 637.
    Renold, A. E., and G. F. Cahill jr.: Adipose tissue. In: Handbook of physiology, Sec. 5. Washington: Amer. Physiol. Soc. 1965.Google Scholar
  639. 638.
    — —Diabetes mellitus. In: J. B. Stanbury, J. B. Wyngaarden and D. S. Frederickson (eds.), The metabolic basis of inherited disease, 2nd ed., p. 69. New York: McGraw-Hill Book Co. 1966.Google Scholar
  640. 639.
    Reuter, J. P., u. K. Ricker: Änderungen des Blutzuckers und des weißen Blutbildes bei der Insulinkoma-Unterbrechung durch Glucagon. Dtsch. Arch. klin. Med. 211, 297 (1965).PubMedGoogle Scholar
  641. 640.
    Riley, G. A., and R. C. Haynes jr.: The effect of adenosine-3′,5′-phosphate on phosphorylase activity in beef adrenal cortex. J. biol. Chem. 238, 1563 (1963).PubMedGoogle Scholar
  642. 641.
    Rizack, M. A.: Activation of an epinephrine-sensitive lipolytic activity from adipose tissue by adenosine-3′,5′-phosphate. J. biol. Chem. 239, 392 (1964).PubMedGoogle Scholar
  643. 642.
    In: A. E. Renold, and G. F. Cahill jr. (eds.), Handbook of physiology, Sec. 5, p. 335. Washington: Amer. Physiol. Soc. 1965.Google Scholar
  644. 643.
    Roberts, S., J. E. Creange, and D. D. Fowler: Stimulation of steroid C-11β-hydroxylase activity in adrenal homogenates by cyclic 3′,5′-adenosine monophosphate. Nature (Lond.) 203, 759 (1964).PubMedGoogle Scholar
  645. 644.
    Robison, G.: Cyclic AMP and the inotropic effect of epinephrine. 150th Meet., Amer. Chemical Society, Atlantic City, September 13–17, 1965.Google Scholar
  646. 645.
    Robison, G. A., R. W. Butcher, and E. W. Sutherland: Adenyl cyclase as an adrenergic receptor. Ann. N.Y. Acad. Sci. 139, 703 (1967).PubMedGoogle Scholar
  647. 646.
    — J. H. Exton, C. R. Park, and E. W. Sutherland: Effect of glucagon and epinephrine on cyclic AMP levels in rat liver. Fed. Proc. 26, 257 (1967).Google Scholar
  648. 647.
    Rodbell, M.: The metabolism of isolated fat cells. IV. Regulation of release of protein by lipolytic hormones and insulin. J. biol. Chem. 241, 3909 (1966).PubMedGoogle Scholar
  649. 648.
    Rodbell, M., and A. B. Jones: Metabolism of isolated fat cells. III. The similar inhibitory action of phospholipase C (Clostridium perfringens α Toxin) and of insulin on lipolysis stimulated by lipolytic hormones and theophylline. J. biol. Chem. 241, 140 (1966).PubMedGoogle Scholar
  650. 649.
    Rodriguez-Candela, J. L., A. M. Castrillón, D. Martín-Hernandez, and T. Castilla-Cortazar: Effect of glucose and citrate on insulin secretion in vitro by the pancreas pretreated with 2-deoxyglucose. Med. exp. 11, 47 (1964).Google Scholar
  651. 650.
    Rojas, J., P. Meneses, and J. L. Rodriguez-Candela: Effect of glucose on insulin secretion in vitro by rabbit pancreas pre-incubated with β-hydroxybutyrate. Nature (Lond.) 203, 758 (1964).PubMedGoogle Scholar
  652. 651.
    Rosell, S.: Release of free fatty acids from subcutaneous adipose tissue in dogs following sympathetic nerve stimulation. Acta physiol. scand. 67, 343 (1966).PubMedGoogle Scholar
  653. 652.
    Rosell-Perez, M., and J. Larner: Studies on UDPG-α-glucan transglucosylase. IV. Purification and characterization of two forms from rabbit skeletal muscle. Biochemistry 3, 75 (1964).PubMedGoogle Scholar
  654. 653.
    Rosen, F., and C. A. Nichol: Corticosteroids and enzyme activity. Vitam. and Horm. 21, 135 (1963).Google Scholar
  655. 654.
    Rosenbloom, A. L., D. W. Smith, and R. C. Cohan: Zinc glucagon in idiopathic hypoglycemia of infancy. Amer. J. Dis. Child. 112, 107 (1966).PubMedGoogle Scholar
  656. 655.
    Ross, B. D., R. Hems, and H. A. Krebs: The rate of gluconeogenesis from various precursors in the perfused rat liver. Biochem. J. 102, 942 (1967).PubMedGoogle Scholar
  657. 656.
    Rosselin, G., G. Tchobroutsky, R. Assan, J. Drouet, J. Dolais, M. Freychet et M. Derot: La méthode radio-immunologique d’étude des hormones protéiques et de leurs anti-corps chez l’homme. Ann. Endocr. (Paris) 26, 449 (1965).PubMedGoogle Scholar
  658. 657.
    Roth, H., S. Thier, and S. Segal: Zinc glucagon in the management of refractory hypoglycemia due to insulin-producing tumors. New Engl. J. Med. 274, 493 (1966).PubMedGoogle Scholar
  659. 658.
    Roth, J., S. M. Glick, R. S. Yalow, and S. A. Berson: Hypoglycemia: a potent stimulus to secretion of growth hormone. Science 140, 987 (1963).PubMedGoogle Scholar
  660. 659.
    — — — —Secretion of human growth hormone: physiologic and experimental modifications. Metabolism 12, 577 (1963).PubMedGoogle Scholar
  661. 660.
    Ruderman, N. B., V. Lauris, and M. G. Herrera: Insulin preservation of glucokinase activity in isolated perfused rat liver. Amer. J. Physiol. 212, 1169 (1967).PubMedGoogle Scholar
  662. 661.
    Rudman, D.: Effect of glucagon on lipid metabolism of fatty tissue in vitro. Res. Symp. on Glucagon. San Francisco, October 7–8, 1966.Google Scholar
  663. 662.
    M. Di Girolamo, and L. A. Garcia: Evolutionary changes in fat cell physiology. Intern. Symp. Pharmacol. Hormonal Polypept. Prot., Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  664. 663.
    Ryan, W. G., A. F. Nibbe, and T. Schwartz: Betacytotrophic effects of glucose, glucagon, and tolbutamide in man. Lancet 1967 II, 1255.Google Scholar
  665. 664.
    —, and T. B. Schwartz: Response of normal and diabetic subjects to intensive islet cell stimulation. Sixth Congr. Intern. Diabetes. Feder., I. C. S. 140, 86 (1967).Google Scholar
  666. 665.
    Salas, M., E. Viñuela, and A. Sols: Insulin-dependent synthesis of liver glucokinase in the rat. J. biol. Chem. 238, 3535 (1963).PubMedGoogle Scholar
  667. 666.
    Salas, M. L., E. Viñuela, M. Salas, and A. Sols: Citrate inhibition of phosphofructokinase and the Pasteur effect. Biochem. biophys. Res. Commun. 19, 371 (1965).PubMedGoogle Scholar
  668. 667.
    Salter, J. M., I. W. F. Davidson, and C. H. Best: Pathologic effects of large amounts of glucagon. Diabetes 6, 248 (1957).PubMedGoogle Scholar
  669. 668.
    — R. de Meyer, and C. H. Best: Effect of insulin and glucagon on tumor growth. Brit. med. J. 1958 II, 5.Google Scholar
  670. 669.
    — C. Ezrin, J. C. Laidlaw, and A. G. Gornall: Metabolic effects of glucagon in human subjects. Metabolism 9, 753 (1960).PubMedGoogle Scholar
  671. 670.
    Samols, E.: Effect of glucagon on insulin release in vivo. Res. Symp. on Glucagon. San Francisco, October 7–8, 1966.Google Scholar
  672. 671.
    Samols, E., G. Marri, and V. Marks: Promotion of insulin secretion by glucagon. Lancet 1965 II, 415.Google Scholar
  673. 672.
    — — —Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes 15, 855 (1966).PubMedGoogle Scholar
  674. 673.
    — J. Tyler, and V. Marks: Glucagon assays. A summary of the clinical and physiological findings. Proc. roy. Soc. Med. 59, 818 (1966).Google Scholar
  675. 674.
    — — G. Marri, and V. Marks: Stimulation of glucagon secretion by oral glucose. Lancet 1965 II, 1257.Google Scholar
  676. 675.
    — — C. Megyesi, and V. Marks: Immunochemical glucagon in human pancreas, gut and plasma. Lancet 1966 II, 727.Google Scholar
  677. 676.
    Sarcione, E. J., N. Back, J. E. Sokal, B. Mehlman, and E. Knoblock: Elevation of plasma epinephrine levels produced by glucagon in vivo. Endocrinology 72, 523 (1963).PubMedGoogle Scholar
  678. 677.
    Satake, M., T. Omori, S. Iwanaga, and T. Suzuki: Studies on snake venoms. XIV. Hydrolyses of insulin B chain and glucagon by proteinase C from Agkistrodon halys blomhoffii venom. J. Biochem. 54, 8 (1963).PubMedGoogle Scholar
  679. 678.
    Schäfer, G., H. Mehnert, G. Kaliampetsos, G. Faust u. E. Gruber: Die Insulinsekretion des Pankreas bei extracorporaler Perfusion. I. Mitt. Material und Methodik, Voruntersuchungen, Kritik und Diskussion. Klin. Wschr. 40, 1141 (1962).Google Scholar
  680. 679.
    Schalch, D. S.: Endogenous glucagon in man. Res. Symp. on Glucagon. San Francisco, October 7–8, 1966.Google Scholar
  681. 680.
    The influence of physical stress and exercise on growth hormone and insulin secretion in man. J. Lab. clin. Med. 69, 256 (1967).PubMedGoogle Scholar
  682. 681.
    —, and D. M. Kipnis: Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J. clin. Invest. 44, 2010 (1965).PubMedGoogle Scholar
  683. 682.
    Schimassek, H.: Lactate metabolism in the isolated perfused liver. Ann. N.Y. Acad. Sci. 119, 1013 (1965).PubMedGoogle Scholar
  684. 683.
    J. Helms, and H. J. Mitzkat: Distinct antagonistic effects of glucagon and insulin in the Embden-Meyerhof chain. Intern. Symp. Pharmacol. Hormonal Polypept. Prot., Advanc. exp. Med. Biol. 2 (in press).Google Scholar
  685. 684.
    —, u. H. J. Mitzkat: Über eine spezifische Wirkung des Glucagon auf die Embden-Meyerhof-Kette der Leber. Versuche an der isoliert perfundierten Rattenleber. Biochem. Z. 337, 510 (1963).PubMedGoogle Scholar
  686. 685.
    Schneemann, K.: Erfahrungen mit Glukagon als neuartigem Mittel zur Beendigung therapeutischer Insulincomata. Schweiz. med. Wschr. 92, 1711 (1962).PubMedGoogle Scholar
  687. 686.
    Schopman, W., W. H. L. Hackeng, and C. Steendijk: The purification of 125I-glucagon of high specific activity for radioimmunochemical estimation of glucagon and a qualitative comparison of glucagon from different sources. Acta endocr. (Kbh.) 54, 527 (1967).PubMedGoogle Scholar
  688. 687.
    Schröder, E.: Über Peptidsynthesen, IV. Neue O-Tert-Butyl-Hydroxyaminosäure-Derivate und ihre Verwendung zur Synthese von Glukagon Teilsequenzen. Ann. Chem. 670, 127 (1963).Google Scholar
  689. 688.
    Über Peptidsynthesen, XXVIII. Über Glukagon-Teilsequenzen. Synthese der N-terminalen Glukagon Teilsequenz 1–11. Ann. Chem. 681, 231 (1965).Google Scholar
  690. 689.
    Über Peptidsynthesen, XXIX. Über Glukagon-Teilsequenzen. Synthese der Glukagon-Teilsequenzen 12–19 und 1–19. Ann. Chem. 681, 241 (1965).Google Scholar
  691. 690.
    Über Peptidsynthesen, XXXVI. Über Glukagon-Synthese. C-terminalen Glukagon-Teilsequenzen. Ann. Chem. 688, 250 (1965).Google Scholar
  692. 691.
    —, u. H. Gibian: Über Peptidsynthesen. XII. Synthese von Glukagon-Teilsequenzen. Ann. Chem. 656, 190 (1962).Google Scholar
  693. 692.
    Schulman, J. L., J. L. Carleton, G. Whitney, and J. C. Whitehorn: Effect of glucagon on food intake and body weight in man. J. appl. Physiol. 11, 419 (1957).PubMedGoogle Scholar
  694. 693.
    Schultz, G., G. Senft u. K. Munske: Der Einfluß von Insulin auf die enzymatische Regulation der Glycogenolyse. Naturwissenschaften 53, 529 (1966).PubMedGoogle Scholar
  695. 694.
    Schuster, T. M.: Possible structural similarity between insulin and glucagon. Nature (Lond.) 209, 302 (1966).PubMedGoogle Scholar
  696. 695.
    Schwartz, I. L., and O. Hechter: Insulin structure and function. Reflections on the present state of the problem. Amer. J. Med. 40, 765 (1966).PubMedGoogle Scholar
  697. 696.
    Schwartz, R., P. A. J. Adam, C. H. Chen, and M. L. McCann: Glucose homeostasis in the newborn. Biol. Neonat. (Basel) 9, 287 (1965–66).PubMedGoogle Scholar
  698. 697.
    Schwartz, S. N.: Influence of starvation and glucose load on the activity of liver phosphorylase in normal and adrenalectomized rats. Nature (Lond.) 180, 857 (1957).Google Scholar
  699. 698.
    Seid-Zade, E. M.: Glucagon formation in a growing chick embryo. Chem. Abstr. 66, 9614 (1967).Google Scholar
  700. 699.
    Selinger, Z., and M. Schramm: An insoluble complex formed by the interaction of muscle phosphorylase with glycogen. Biochem. biophys. Res. Commun. 12, 208 (1963).PubMedGoogle Scholar
  701. 700.
    Seyffert, W., B. Barker, and L. L. Madison: The in vivo effects of changes in plasma free fatty acids on hepatic glucose output and peripheral glucose utilization. Proc. 26th Ann. Meet. Amer. Diabetes Ass. Chicago, 1966, p 12.Google Scholar
  702. 701.
    Shackney, S. E., and C. D. Joel: Stimulation of glucose metabolism in brown adipose tissue by addition of insulin in vitro. J. biol. Chem. 241, 4004 (1966).PubMedGoogle Scholar
  703. 702.
    Sharma, C., R. Manjeshwar, and S. Weinhouse: Effects of diet and insulin on glucose-adenosine triphosphate phosphotransferases of rat liver. J. biol. Chem. 238, 3840 (1963).PubMedGoogle Scholar
  704. 703.
    Sharma, K. N., B. K. Anand, S. Dua, and B. Singh: Hypothalamic feeding centers. Amer. J. Physiol. 201, 593 (1961).PubMedGoogle Scholar
  705. 704.
    Shaw, J. E.: Prostaglandin release from adipose tissue in vitro evoked by nerve stimulation or catecholamines. Fed. Proc. 25, 770 (1966).Google Scholar
  706. 705.
    Sheps, S. G., and F. T. Maher: Comparison of glucagon and histamine tests in diagnosis of pheochromocytoma. Circulation 36, Suppl. 2, 236 (1967).Google Scholar
  707. 706.
    Sheyanov, G. G.: Effect of massive dosage of glucose on histologic structure and functional state of the islands of Langerhans. Fed. Proc. 23, T 1296 (1964).Google Scholar
  708. 707.
    Shieber, W.: Insulin-producing Zollinger-Ellison tumor. Surgery 54, 448 (1963).PubMedGoogle Scholar
  709. 708.
    Shigeta, Y., and W. W. Shreeve: Fatty acid synthesis from glucose-1-H3 and glucose-1-C14 in obese-hyperglycemic mice. Amer. J. Physiol. 206, 1085 (1964).PubMedGoogle Scholar
  710. 709.
    Shima, K., and P. P. Foà: Unpublished observations.Google Scholar
  711. 710.
    — — A double-antibody radioimmunoassay for glucagon. In press.Google Scholar
  712. 711.
    Shimazu, T.: Glycogen synthetase activity in liver: regulation by the autonomic nerves. Science 156, 1256 (1967).PubMedGoogle Scholar
  713. 712.
    —, and A. Fukuda: Increased activities of glycogenolytic enzymes in liver after splanchnic-nerve stimulation. Science 150, 1607 (1965).PubMedGoogle Scholar
  714. 713.
    — —, and T. Ban: Reciprocal influences on the ventromedial and lateral hypothalamic nuclei on blood glucose level and liver glycogen content. Nature (Lond.) 210, 1178 (1966).PubMedGoogle Scholar
  715. 714.
    Shipp, J. C., H. K. Delcher, and J. F. Munroe: Treatment of insulin hypoglycemia in diabetic campers. A comparison of glucagon (1 and 2 mg) and glucose. Diabetes 13, 645 (1964).PubMedGoogle Scholar
  716. 715.
    Shrago, E., H. A. Lardy, R. C. Nordlie, and D. O. Foster: Metabolic and hormonal control of phosphoenolpyruvate carboxykinase and malic enzyme in rat liver. J. biol. Chem. 238, 3188 (1963).PubMedGoogle Scholar
  717. 716.
    Sie, H.-G., A. Hablanian, and W. H. Fishman: Solubilization of mouse liver glycogen synthetase and phosphorylase during starvation glycogenolysis and its reversal by cortisol. Nature (Lond.) 201, 393 (1964).PubMedGoogle Scholar
  718. 717.
    Simpson, R. G., A. Benedetti, G. M. Grodsky, J. H. Karam, and P. H. Forsham: Stimulation of insulin release by glucagon in noninsulin-dependent diabetics. Metabolism 15, 1046 (1966).PubMedGoogle Scholar
  719. 718.
    — — J. H. Karam, and G. M. Grodsky: Early stimulatory effects of glucose and glucagon on serum insulin levels in man. Clin. Res. 14, 288 (1966).Google Scholar
  720. 719.
    Singh, I.: On argyrophile and argentaffine reactions in individual granules of enterochromaffin cells of the human gastrointestinal tract. J. Anat. (Lond.) 98, 497 (1964).PubMedGoogle Scholar
  721. 720.
    Sirek, A., E. Geerling, and H. Doolan: The nature of the hyperglycemic substance released by growth hormone. Proc. 5th Congr. Intern. Diabetes Federation. Toronto, July 1964.Google Scholar
  722. 721.
    — —, and O. V. Sirek: Serotonin as the hyperglycemic substance released by growth hormone. Amer. J. Physiol. 211, 1018 (1966).PubMedGoogle Scholar
  723. 722.
    Sivadas, P.: The occurrence of β-cells in the islets of Langerhans of Tilapia mossambica (Peters) (Teleostei). Gen. comp. Endocr. 4, 295 (1964).Google Scholar
  724. 723.
    Smith, G. S., and B. C. Johnson: Glucose metabolism in the rat during starvation and refeeding following starvation. Proc. Soc. exp. Biol. (N. Y.) 115, 438 (1964).PubMedGoogle Scholar
  725. 724.
    Snedecor, J. G., D. B. King, and R. C. Henrikson: Studies on the chick glycogen body: effects of hormones and normal glycogen turnover. Gen. comp. Endocr. 3, 176 (1963).PubMedGoogle Scholar
  726. 725.
    Sneyd, J. G. T., R. W. Butcher, E. W. Sutherland, and C. R. Park: The effect of insulin on adenosine 3′,5′-phosphate (cyclic AMP) in adipose tissue. Fed. Proc. 25, 584 (1966).Google Scholar
  727. 726.
    Snyder, R. D., and A. Robinson: Leucine-induced hypoglycemia. Amer. J. Dis. Child. 113, 566 (1967).PubMedGoogle Scholar
  728. 727.
    Sodoyez, J. C., A. S. Luyckx, and J. L. Lefebvre: Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals. Diabetes 16, 415 (1967).PubMedGoogle Scholar
  729. 728.
    Sokal, J. E.: Glucagon — An essential hormone. Amer. J. Med. 41, 331 (1966).PubMedGoogle Scholar
  730. 729.
    — Effect of glucagon on catecholamine production. Res. Symp. on Glucagon, San Francisco. October 7–8, 1966.Google Scholar
  731. 730.
    Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. Endocrinology 78, 538 (1966).PubMedGoogle Scholar
  732. 731.
    — A. Aydin, and G. Kraus: Effect of glucagon on plasma free fatty acids of normal and pancreatectomized dogs. Amer. J. Physiol. 211, 1334 (1966).PubMedGoogle Scholar
  733. 732.
    —, and E. Z. Ezdinli: Basal plasma glucagon levels of man. J. clin. Invest. 46, 778 (1967).PubMedGoogle Scholar
  734. 733.
    — C. U. Lowe, E. J. Sarcione, L. L. Moscovich, and B. H. Doray: Studies of glycogen metabolism in liver glycogen disease (von Gierke’s disease): six cases with similar metabolic abnormalities and responses to glucagon. J. clin. Invest. 40, 364 (1961).PubMedGoogle Scholar
  735. 734.
    — E. J. Sarcione, and A. M. Henderson: Relative potency of glucagon and epinephrine as hepatic glycogenolytic agents: studies with the isolated perfused rat liver. Endocrinology 74, 930 (1964).PubMedGoogle Scholar
  736. 735.
    —, and B. Weintraub: Failure of the isolated liver to react to hypoglycemia. Amer. J. Physiol. 210, 63 (1966).Google Scholar
  737. 736.
    Solcia, E.: Osservazioni istochimiche sulla distribuzione della glucosio-6-fosfato deidrogenasi nelle isole pancreatiche. Boll Soc. ital. Biol. sper. 39, 1092 (1963).PubMedGoogle Scholar
  738. 737.
    Enzimoistochimica e luminosità in campo oscuro delle isole pancreatiche del ratto allossanato. Boll. Soc. ital. Biol. sper. 39, 1094 (1963).PubMedGoogle Scholar
  739. 738.
    —, and R. Sampietro: On the nature of the metachromatic cells of pancreatic islets. Z. Zellforsch. 65, 131 (1965).Google Scholar
  740. 739.
    Söling, H. D., P. Kneer, W. Drägert u. W. Creutzfeldt: Die Wirkung von Insulin auf den Stoffwechsel der isolierten perfundierten Leber normaler und Alloxan-diabetischer Ratten. II. Stoffwechseländerungen unter dem Einfluß intraportaler Insulininfusionen. Diabetologia 2, 32 (1966).PubMedGoogle Scholar
  741. 740.
    — R. Koschel, W. Drägert, P. Kneer u. W. Creutzfeldt: Die Wirkung von Insulin auf den Stoffwechsel der isolierten perfundierten Leber normaler und Alloxan-diabetischer Ratten. I. Der Stoffwechsel isolierter perfundierter Lebern von normalen und Alloxan-diabetischen Ratten unter verschiedenen experimentellen Bedingungen. Diabetologia 2, 20 (1966).PubMedGoogle Scholar
  742. 741.
    Sols, A., A. Sillerto, and J. Salas: Insulin-dependent synthesis of glucokinase. J. cell. comp. Physiol. 66 (Suppl. I, part II) 23 (1965).Google Scholar
  743. 742.
    Spann, J. F. jr., E. H. Sonnenblick, T. Cooper, C. A. Chidsey, V. L. Willman, and E. Braunwald: Cardiac norepinephrine stores and the contractile state of heart muscle. Circulat. Res. 19, 317 (1966).PubMedGoogle Scholar
  744. 743.
    Staib, W., u. H. Reinauer: Der Einfluß von Hypophysenhormonen auf den Kohlenhydratstoffwechsel. In: H. Bartelheimer, W. Heyde u. W. Thorn (Hrsg.), D-Glucose und verwandte Verbindungen in Medizin und Biologie, S. 455. Stuttgart: Ferdinand Enke 1966.Google Scholar
  745. 744.
    Stansfield, D. A., and J. W. Robinson: Glycogen and phosphorylase in bovine and rat corpora lutea, and the effect of luteinizing hormone. Endocrinology 76, 390 (1965).PubMedGoogle Scholar
  746. 745.
    Steele, J. E.: The site of action of insect hyperglycemic hormone. Gen. comp. Endocr. 3, 46 (1963).Google Scholar
  747. 746.
    Steele, R.: The influences of insulin on the hepatic metabolism of glucose. Ergebn. Physiol. 57, 91 (1966).PubMedGoogle Scholar
  748. 747.
    Steinberg, D.: Prostaglandins as adrenergic antagonists. Ann. N.Y. Acad. Sci. 139, 897 (1967).PubMedGoogle Scholar
  749. 748.
    —, and R. Pittman: Depression of plasma FFA levels in unanesthetized dogs by single intravenous doses of prostaglandin E. Proc. Soc. exp. Biol. (N.Y.) 123, 192 (1966).PubMedGoogle Scholar
  750. 749.
    — M. Vaughan, P. J. Nestel, O. Strand, and S. Bergström: Effects of the prostaglandins on hormone-induced mobilization of free fatty acids. J. clin. Invest. 43, 1533 (1964).PubMedGoogle Scholar
  751. 750.
    Steiner, G., and G. F. Cahill jr.: Adipose tissue physiology. Ann. N.Y. Acad. Sci. 110, 749 (1963).PubMedGoogle Scholar
  752. 751.
    Stöcker, E., C. Hauswaldt u. O. Klinge: Autoradiographische Untersuchungen zum Nukleinsäure-und Eiweißstoffwechsel der Inselzellen von Ratten unter normalen und pathologischen Bedingungen. Beitr. path. Anat. 133, 1 (1966).Google Scholar
  753. 752.
    Stokes, J. M., H. J. Wohltmann, and A. F. Hartmann sr.: Pancreatectomy for refractory hypoglycemia in children. Arch. Surg. 93, 40 (1966).PubMedGoogle Scholar
  754. 753.
    Stowers, J. M., and J. M. Stein: The glucose-fatty acid cycle and human diabetes. Proc. Nutr. Soc. 25, 67 (1966).PubMedGoogle Scholar
  755. 754.
    Strand, L. J., A. Goldfien, and W. F. Ganong: Effect of pancreatectomy on the adrenal medullary response to hypoglycemia in the dog. Endocrinology 74, 656 (1964).PubMedGoogle Scholar
  756. 755.
    Struck, E., J. Ashmore u. O. Wieland: Stimulierung der Gluconeogenese durch langkettige Fettsäuren und Glucagon. Biochem. Z. 343, 107 (1965).PubMedGoogle Scholar
  757. 756.
    — — —Effects of glucagon and long-chain fatty acids on glucose production by isolated perfused rat liver. Advanc. Enzyme Regul. 4, 219 (1966).Google Scholar
  758. 757.
    Stunkard, A. J., T. B. van Itallie, and B. B. Reis: The mechanism of satiety: effect of glucagon on gastric hunger contractions in man. Proc. Soc. exp. Biol. (N.Y.) 89, 258 (1955).PubMedGoogle Scholar
  759. 758.
    Sudsaneh, S., and J. Mayer: Relation of metabolic events to gastric contractions in the rat. Amer. J. Physiol. 197, 269 (1959).PubMedGoogle Scholar
  760. 759.
    Sugimoto, R., M. Abe, S. Ikawa, T. Morita, K. Inokuma, S. Y. Duer, S. Nakano, H. Kamikura, H. Suzuki, M. Nakahara, A. Sasaki, and K. Nishiyama: Studies on the physiologic role of glucagon. Tokyo Jikeikai Sch. Med. 4, 98 (1957).Google Scholar
  761. 760.
    Sussman, K. E., and G. D. Vaughan: Insulin release after ACTH, glucagon, and adenosine-3′-5′-phosphate (cyclic AMP) in the perfused isolated rat pancreas. Diabetes 16, 449 (1967).PubMedGoogle Scholar
  762. 761.
    — —, and R. F. Timmer: Factors controlling insulin secretion from the perfused isolated rat pancreas. Proc. 26th Annual Meet. Amer. Diabetes Ass., Chicago 1966, p. 18.Google Scholar
  763. 762.
    Sutherland, E. W., I. Øye, and R. W. Butcher: The action of epinephrine and the role of the adenyl cyclase system in hormone action. Recent Progr. Hormone Res. 21, 623 (1965).PubMedGoogle Scholar
  764. 763.
    — T. W. Rall, and T. Menon: Adenyl cyclase. I. Distribution, preparation and properties. J. biol. Chem. 237, 1220 (1962).PubMedGoogle Scholar
  765. 764.
    —, and G. A. Robinson: The role of cyclic-3′,5′-AMP in responses to catecholamines and other hormones. Pharmacol. Rev. 18, 145 (1966).PubMedGoogle Scholar
  766. 765.
    Suzuki, Y.: Glucagon. V. The effect of glucagon on the cyclophorase system. Tokyo Jikeikai Ika Daigaku Zasshi 76, 2615 (1961). Chem. Abstr. 61, 12280h (1964).Google Scholar
  767. 766.
    Takeda, Y., H. Inone, K. Honjo, H. Tanioka, and Y. Daikuhara: Dietary response of various key enzymes related to glucose metabolism in normal and diabetic rat liver. Biochim. biophys. Acta (Amst.) 136, 214 (1967).PubMedGoogle Scholar
  768. 767.
    Täljedal, I.-B., B. Hellman, and C. Hellerström: Quantitative studies on isolated pancreatic islets of mammals: enzymic hydrolysis of nucleoside diphosphates and p-nitrophenyl phosphate in normal and cortisone-treated rats. J. Endocr. 36, 115 (1966).PubMedGoogle Scholar
  769. 768.
    — — B. Petersson, and C. Hellerström: Effect of glucagon on the alkaline phosphatase activity in the pancreatic islets of rats. Nature (Lond.) 209, 409 (1966).PubMedGoogle Scholar
  770. 769.
    Tarrant, M. E., R. Mahler, and J. Ashmore: Studies in experimental diabetes. IV. Free fatty acid mobilization. J. biol. Chem. 239, 1714 (1964).PubMedGoogle Scholar
  771. 770.
    Tarui, S., G. Okuno, Y. Ikura, T. Tanaka, M. Suda, and M. Nishikawa: Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem. biophys. Res. Commun. 19, 517 (1965).PubMedGoogle Scholar
  772. 771.
    Tashima, L., and G. F. Cahill jr.: Role of glucagon and insulin in the carbohydrate metabolism of the toadfish. Proc. 5th Congr. Intern. Diabetes Federation. Toronto, July 1964.Google Scholar
  773. 772.
    Tchetchik, M., and L. Shalom: Cancer des cellules alpha du pancréas. Harefuah J. Med. (Israel) 48, 121 (1955).Google Scholar
  774. 773.
    Tepperman, H. M., and J. Tepperman: Adaptive hyperlipogenesis. Fed. Proc. 23, 73 (1964).PubMedGoogle Scholar
  775. 774.
    Théret, C.: La neuro-sécrétion des complexes neuroinsulaires du pancréas. Ses variations sous l’action de stress expérimentaux. Ann. Endocr. (Paris) 22, 312 (1961).PubMedGoogle Scholar
  776. 775.
    Thiery, J. P., et J. P. Bader: Ultrastructure des îlots de Langerhans du pancréas humain normal et pathologique. Ann. Endocr. (Paris) 27, 625 (1966).Google Scholar
  777. 776.
    Thomas, J. A.: Modification of glucagon-induced hyperglycemia by various steroidal agents. Metabolism 12, 207 (1963).PubMedGoogle Scholar
  778. 777.
    Thommes, R. C.: A histochemical study of insulin in the chick embryo pancreas. Growth 24, 69 (1960).PubMedGoogle Scholar
  779. 778.
    Threlfall, C. J.: Role of glucose 6-phosphate in the synthesis of glycogen by the rat liver in vivo. Nature (Lond.) 211, 1192 (1966).PubMedGoogle Scholar
  780. 779.
    Tobin, J., R. Swerdloff, and R. Andres: GI insulin-stimulating factor in man: Plasma insulin response to oral and IV glucose at controlled arterial glucose concentration. Clin. Res. 14, 478 (1966).Google Scholar
  781. 780.
    Tobin, R. B., and W. A. Coleman: A family study of phosphorylase deficiency in muscle. Ann. intern. Med. 62, 313 (1965).PubMedGoogle Scholar
  782. 781.
    Tomizawa, H. H., and S. Kakiuchi: Studies on a glucagon-degrading enzyme of beef liver. Fed. Proc. 21, 200 (1962).Google Scholar
  783. 782.
    Torrontegui, D. de, and J. Berthet: The action of adrenalin and glucagon on the metabolism of phospholipids in rat liver. Biochim. biophys. Acta (Amst.) 116, 467 (1966).PubMedGoogle Scholar
  784. 783.
    Traut, R. R., and F. Lipman: Activation of glycogen synthetase by glucose 6-phosphate. J. biol. Chem. 238, 1213 (1963).PubMedGoogle Scholar
  785. 784.
    Triner, L., et G. G. Nahas: Effects de la théophylline sur le métabolisme des lipides et des glucides chez le rat blanc. C. R. Soc. Biol. (Paris) 160, 1905 (1966).Google Scholar
  786. 785.
    Tuchman-Duplessis, H., et L. Mercier-Parot: Production de malformations congénitales chez le rat traité par le glucagon. C. R. Acad. Sci. (Paris) 254, 2655 (1962).Google Scholar
  787. 786.
    Turner, D. S., and N. McIntyre: Stimulation by glucagon of insulin release from rabbit pancreas in vitro. Lancet 1966I, 351.Google Scholar
  788. 787.
    Tyberghein, J. M.: Action du glucagon sur le métabolism des protéines. Arch. int. Physiol. Biochem. 61, 104 (1953).Google Scholar
  789. 788.
    Ueda, I., K. Fukushima, and R. W. Loehning: Influences of anesthetics on chronotropic effect of glucagon. Arch. int. Pharmacodyn. 158, 234 (1965).PubMedGoogle Scholar
  790. 789.
    Ueki, H., and S. Hayashi: Influence of quinone derivatives on insulin, glucagon and insulinase. II. Influence of quinone derivatives on blood sugar increasing action of glucagon. Yakugaku Zasshi 82, 654 (1962).PubMedGoogle Scholar
  791. 790.
    Uete, T., and J. Ashmore: Effects of triamcinolone on carbohydrate synthesis by rat liver slices. J. biol. Chem. 238, 2906 (1963).PubMedGoogle Scholar
  792. 791.
    Underwood, A. H., and E. A. Newsholme: Properties of phosphofructokinase from rat liver and their relation to the control of glycolysis and gluconeogenesis. Biochem. J. 95, 868 (1965).PubMedGoogle Scholar
  793. 792.
    — —Some properties of phosphofructokinase from kidney cortex and their relation to glucose metabolism. Biochem. J. 104, 296 (1967).PubMedGoogle Scholar
  794. 793.
    — —Control of glycolysis and gluconeogenesis in rat kidney cortex slices. Biochem. J. 104, 300 (1967).PubMedGoogle Scholar
  795. 794.
    Unger, R. H.: Endogenous glucagon in man and animals. Res. Symp. on Glucagon. San Francisco, October 7–8, 1966.Google Scholar
  796. 795.
    Glucoregulatory hormones in health and disease. A teleologic model. Diabetes 15, 500 (1966).PubMedGoogle Scholar
  797. 796.
    The riddle of tumor hypoglycemia. Amer. J. Med. 40, 325 (1966).PubMedGoogle Scholar
  798. 797.
    — Tissue distribution of glucagon. Res. Symp. on Glucagon. San Francisco, October 7–8, 1966.Google Scholar
  799. 798.
    — Personal communication.Google Scholar
  800. 799.
    —and A. M. Eisentraut: Studies of the physiologic role of glucagon. Diabetes 13, 563 (1964).PubMedGoogle Scholar
  801. 800.
    — —Studies on the physiologic role of glucagon. In: B. S. Leibel and G. A. Wrenshall (eds.), On the nature and treatment of diabetes, p. 274. Amsterdam: Excerpta Med. Found. 1965.Google Scholar
  802. 801.
    — —Études récentes sur la physiologie du glucagon. 8e Journ. Ann. Diab. Hôtel-Dieu, p. 7. Paris: Méd. Flammarion 1967.Google Scholar
  803. 802.
    — — S. E. Brolin, and G. Lundquist: The cellular site of pancreatic glucagon production. Sixth Congr. Intern. Diabetes Feder., Excerpta Med., I. C. S. No 140, 98 (1967).Google Scholar
  804. 803.
    — —, and L. L. Madison: The effects of total starvation upon the levels of circulating glucagon and insulin in man. J. clin. Invest. 42, 1031 (1963).PubMedGoogle Scholar
  805. 804.
    — — M. S. McCall, S. Keller, and L. L. Madison: Production of glucagon antibodies and the development of an immunoassay for glucagon. J. Lab. clin. Med. 54, 952 (1959).Google Scholar
  806. 805.
    Unger, R. H., A. M. Eisentraut, M. S. McCall, and L. L. Madison: Glucagon antibodies and an immunoassay for glucagon. J. clin. Invest. 40, 1280 (1961).PubMedGoogle Scholar
  807. 806.
    — — — —Demonstration of the hormonal status of endogenous glucagon. Ciba Foundation Colloquia Endocr. 14, 212 (1962).Google Scholar
  808. 807.
    — — — —Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. J. clin. Invest. 41, 682 (1962).PubMedGoogle Scholar
  809. 808.
    — H. Ketterer, J. Dupré, and A. M. Eisentraut: The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J. clin. Invest. 46, 630 (1967).PubMedGoogle Scholar
  810. 809.
    — — and A. M. Eisentraut: Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism 15, 865 (1966).PubMedGoogle Scholar
  811. 810.
    — — —, and J. Dupré: Effect of secretin on insulin secretion. Lancet 1966II, 24.Google Scholar
  812. 811.
    — J. de V. Lochner, and A. M. Eisentraut: Identification of insulin and glucagon in a bronchogenic metastasis. J. clin. Endocr. 24, 823 (1964).PubMedGoogle Scholar
  813. 812.
    Vaughan, M.: Effect of hormones on glucose metabolism in adipose tissue. J. biol. Chem. 236, 2196 (1961).PubMedGoogle Scholar
  814. 813.
    The mechanisms of the lipolytic action of catecholamines. Ann. N. Y. Acad. Sci. 139, 841 (1967).Google Scholar
  815. 814.
    — J. E. Berger, and D. Steinberg: Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue. J. biol. Chem. 239, 401 (1964).Google Scholar
  816. 815.
    Vecchio, D., A. Luyckx, G. R. Zahnd, and A. E. Renold: Insulin release induced by glucagon in organ cultures of fetal rat pancreas. Metabolism 15, 577 (1966).PubMedGoogle Scholar
  817. 816.
    Verne, J., S. Guha, P. Petokov et R. Wegmann: Effet in vivo du glucagon sur le glycogène et sur la phosphorylase hépatique du lapin. Ann. Histochim. 6, 137 (1961).PubMedGoogle Scholar
  818. 817.
    —, et S. Hébert: Action du glucagon sur les hépatocytes en culture. C. R. Soc. Biol. (Paris) 157, 984 (1963).Google Scholar
  819. 818.
    — —Action d’un sulfamide hypoglycémiant (Tolbutamide) sur la teneur en glycogène d’hépatocytes en culture; comparison avec l’action du glucagon. C. R. Soc. Biol. (Paris) 158, 682 (1964).Google Scholar
  820. 819.
    —, et P. Petkov: Images histologiques du pancréas endocrine sous l’action du glucagon. Ann. Endocr. (Paris) 22, 965 (1961).PubMedGoogle Scholar
  821. 820.
    Vester, J. W., and M. L. Reino: Hepatic glucokinase: a direct effect of insulin. Science 142, 590 (1963).PubMedGoogle Scholar
  822. 821.
    Villar-Palasi, C., and J. Larner: Levels of activity of the enzymes of the glycogen cycle in rat tissues. Arch. Biochem. 86, 270 (1960).PubMedGoogle Scholar
  823. 822.
    Volk, B. W., and S. S. Lazarus: Studies on the diabetogenic action and site of origin of glucagon. Diabetes 9, 53 (1960).Google Scholar
  824. 823.
    — K. F. Wellmann, and A. Lewitan: The effect of irradiation on the fine structure and enzymes of the dog pancreas. I. Short-term studies. Amer. J. Path. 48, 721 (1966).PubMedGoogle Scholar
  825. 824.
    Volpé, R., J. Evans, D. W. Clarke, N. Forbath, and R. Ehrlich: Evidence favoring the sarcomatous origin of an insulin-like substance in a case of fibrosarcoma with hypoglycemia. Amer. J. Med. 38, 540 (1965).PubMedGoogle Scholar
  826. 825.
    Wagle, S. R.: The influence of growth hormone, cortisol and insulin on the incorporation of amino acids into protein. Arch. Biochem. 102, 373 (1963).PubMedGoogle Scholar
  827. 826.
    Studies on pyruvate carboxylase activity in alloxan diabetic and normal animals. Biochem. biophys. Res. Commun. 14, 533 (1964).PubMedGoogle Scholar
  828. 827.
    Studies on mechanism of glucose synthesis in diabetic and normal rat liver. Diabetes 15, 19 (1966).PubMedGoogle Scholar
  829. 828.
    —, and J. Ashmore: Studies on experimental diabetes. III. Effects of acute insulin insufficiency on 14C-glucose formation from labeled substrates. J. biol. Chem. 239, 1289 (1964).PubMedGoogle Scholar
  830. 829.
    Walker, D. G.: On the presence of two soluble glucose-phosphorylating enzymes in adult liver and the development of one of these after birth. Biochim. biophys. Acta (Amst.) 77, 209 (1963).PubMedGoogle Scholar
  831. 830.
    —, and S. Rao: The role of glucokinase in the phosphorylation of glucose by rat liver. Biochem. J. 90, 360 (1964).PubMedGoogle Scholar
  832. 831.
    Wallace, J. M., and W. R. Harlan: Significance of epinephrine in insulin hypoglycemia in man. Amer. J. Med. 38, 531 (1965).PubMedGoogle Scholar
  833. 832.
    Wang, J. H., M. L. Shonka, and D. J. Graves: Influence of carbohydrates on phosphorylase structure and activity. I. Activation by preincubation with glycogen. Biochemistry 4, 2296 (1965).Google Scholar
  834. 833.
    Wattenwyl, N. v.: Neuere Differenzierungsmethoden der Langerhansschen Inseln. Path. et Microbiol. (Basel) 27, 144 (1964).Google Scholar
  835. 834.
    Weber, G., S. V. Bhide, and S. S. Manwaring: An in vitro system for studying hormonal induction of hepatic gluconeogenic enzymes. Biochem. biophys. Res. Commun. 16, 167 (1964).PubMedGoogle Scholar
  836. 835.
    —, and A. Cantero: Human liver enzymes of glucose-6-phosphate utilization. Science 126, 977 (1957).PubMedGoogle Scholar
  837. 836.
    —, and H. J. H. Convery: Insulin. Inducer of glucose-6-phosphate dehydrogenase. Life Sci. 5, 1139 (1966).PubMedGoogle Scholar
  838. 837.
    —, and R. L. Singhal: Insulin: Inducer of phosphofructokinase. The integrative action of insulin at the enzyme biosynthetic level. Life Sic. 4, 1993 (1965).Google Scholar
  839. 838.
    — N. B. Stamm, and E. A. Fisher: Insulin: Inducer of pyruvate kinase. Science 149, 65 (1965).PubMedGoogle Scholar
  840. 839.
    Wegienka, L. C., G. M. Grodsky, J. H. Karam, S. G. Grasso, and P. H. Forsham: Comparison of insulin and 2-deoxy-d-glucose-induced glucopenia as stimulators of growth hormone secretion. Metabolism 16, 245 (1967).PubMedGoogle Scholar
  841. 840.
    Wegmann, R., et P. Petkov: Histoenzymologie du pancreas endocrine de l’homme. Histochemie 6, 336 (1966).PubMedGoogle Scholar
  842. 841.
    Weinges, K. F.: Der Einfluß eines protrahiert wirkenden Glucagons auf den Blutzucker, das anorganische Serumphosphat und die Gesamtaminosäuren im Serum. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 237, 22 (1959).Google Scholar
  843. 842.
    Beitrag zur Klärung der Frage einer anabolen oder katabolen Stoffwechselwirkung des zweiten Pankreashormones Glucagon (HGF). Symp. dtsch. Ges. Endokr., April 1960, S. 167.Google Scholar
  844. 843.
    —, u. G. Löffler: Glucagon-empfindliche lipolytische Aktivität im Fettgewebe. Klin. Wschr. 43, 175 (1965).PubMedGoogle Scholar
  845. 844.
    Weiss, B., and E. Costa: Adenyl cyclase activity in rat pineal gland: effects of chronic denervation and norepinephrine. Science 156, 1750 (1967).PubMedGoogle Scholar
  846. 845.
    Weiss, I.: Untersuchungen zur Frage der zentralnervösen Regulation der A-Zell-funktion am Pankreas der Albinoratte. I. Das Verhalten des A-Zellzinks der Ratte nach Adrenektomie und Insulinbelastung. Endokrinologie 47, 183 (1965).PubMedGoogle Scholar
  847. 846.
    Wenke, M., D. Lincová, J. Čepelík, M. Cernohorský, and S. Hynie: Some aspects of the action of beta adrenergic blocking drugs on adrenergic lipid mobilization. Ann. N.Y. Acad. Sci. 139, 860 (1967).PubMedGoogle Scholar
  848. 847.
    Weygand, F., u. E. Nintz: Weitere Peptidsynthesen mit pMZ-Aminosäuren. Z. Naturforsch. 20b, 429 (1965).Google Scholar
  849. 848.
    White, R. G.: Immunochemical methods in hormone research. In: P. Eckstein and F. Knowles (eds), Techniques in endocrine research, p. 133. New York: Academic Press 1963.Google Scholar
  850. 849.
    Whitehouse, F. W., and T. N. James: Chronotropic action of glucagon on the sinus node. Proc. Soc. exp. Biol. (N.Y.) 122, 823 (1966).PubMedGoogle Scholar
  851. 850.
    Whitty, A. J., K. Shima, M. Trubow, and P. P. Foà: Effect of glucagon on serum FFA in normal and depancreatized dogs. Fed. Proc. 26, 15 (1967).Google Scholar
  852. 851.
    Wiesel, L. L., V. Positano, Y. Kologlu, and G. E. Anderson: Chromatographic separation of glucagon and insulin from serum by resin-exchange paper. Proc. Soc. exp. Biol. (N. Y.) 112, 515 (1963).PubMedGoogle Scholar
  853. 852.
    Wilber, J. F., J. R. Turtle, and N. A. Crane: Inhibition of insulin secretion by a pheochromocytoma. Lancet 1966II, 733.Google Scholar
  854. 853.
    Williams, B. J., and S. E. Mayer: Hormonal effects on glycogen metabolism in the rat heart in situ. Molec. Pharmacol. 2, 454 (1966).Google Scholar
  855. 854.
    Williams, H. E., and J. B. Field: Further studies on leukocyte phosphorylase in glycogen storage disease. Metabolism 12, 464 (1963).PubMedGoogle Scholar
  856. 855.
    — P. L. Johnson, and J. B. Field: An effect of anterior pituitary hormones on bovine corpus luteum phosphorylase. Biochem. biophys. Res. Commun. 6, 129 (1961).PubMedGoogle Scholar
  857. 856.
    Williamson, J. R.: Effects of insulin and diet on the metabolism of l (+)-lactate and glucose by the perfused rat heart. Biochem. J. 83, 377 (1962).PubMedGoogle Scholar
  858. 857.
    Glycolytic control mechanisms. I. Inhibition of glycolysis by acetate and pyruvate in the isolated perfused rat heart. J. biol. Chem. 240, 2308 (1965).PubMedGoogle Scholar
  859. 858.
    Possible role of citrate in the control of epinephrine-stimulated glycogenolysis in the rat heart. Nature (Lond.) 206, 473 (1965).PubMedGoogle Scholar
  860. 859.
    Williamson, J. R. Mechanism for the stimulation in vivo of hepatic gluconeogenesis by glucagon. Biochem. J. 101, 11c (1966).Google Scholar
  861. 860.
    — A. Garcia, A. E. Renold, and G. F. Cahill Jr.: Studies on the perfused rat liver. I. Effects of glucagon and insulin on glucose metabolism. Diabetes 15, 183 (1966).PubMedGoogle Scholar
  862. 861.
    — B. Herczeg, H. Coles, and R. Danish: Ketogenic effect of glucagon in intact rat liver. Biochem. biophys. Res. Commun. 24, 437 (1966).PubMedGoogle Scholar
  863. 862.
    — R. A. Kreisberg, and P. W. Felts: Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. nat. Acad. Sci. (Wash.) 56, 247 (1966).PubMedGoogle Scholar
  864. 863.
    —, and M. S. Olson: Regulation of gluconeogenesis in liver. Fed. Proc. 26, 563 (1967).Google Scholar
  865. 864.
    — P. H. Wright, W. J. Malaisse, and J. Ashmore: Control of gluconeogenesis by acetyl CoA in rats treated with glucagon and antiinsulin serum. Biochem. biophys. Res. Commun. 24, 765 (1966).Google Scholar
  866. 865.
    Wilson, W. P., M. J. Short, and W. P. Deiss Jr.: The relationship of glucagon and EEG patterns in hypoglycemia. J. psychiat. Res. 3, 99 (1965).PubMedGoogle Scholar
  867. 866.
    Windladh, L.: Light microscopical and ultrastructural studies of the pancreatic islet tissue of the lamprey (Lampetra fluviatilis). Gen. comp. Endocr. 6, 534 (1966).Google Scholar
  868. 867.
    Winborn, W. B.: Light and electron microscopy of the islets of Langerhans of the Saimiri monkey pancreas. Anat. Rec. 147, 65 (1963).PubMedGoogle Scholar
  869. 868.
    Winkler, B., R. Steele, N. Altszuler, and R. C. de Bodo: Effect of growth hormone on free fatty acid metabolism. Amer. J. Physiol. 206, 174 (1964).PubMedGoogle Scholar
  870. 869.
    Wolfson, S. K. Jr., and S. Ellis: Effects of glucagon on plasma potassium. Proc. Soc. exp. Biol. (N.Y.) 91, 226 (1956).PubMedGoogle Scholar
  871. 870.
    Wood, F. C. Jr., and D. Porte Jr.: A new role for glucagon. Ann. intern. Med. 66, 812 (1967).PubMedGoogle Scholar
  872. 871.
    Wool, I. G., and P. Cavicchi: Insulin regulation of protein synthesis by muscle ribosomes: effect of the hormone on translation of messenger RNA for a regulatory protein. Proc. nat. Acad. Sci. (Wash.) 56, 991 (1966).PubMedGoogle Scholar
  873. 872.
    Wörner, H., u. K. F. Weinges: Über den Einfluß von Insulin und Glukagon auf den Glucosestoffwechsel des epididymalen Fettanhanges der Ratte in vitro. II. Der Einfluß von Glukagon im Vergleich mit dem Insulineffekt. Klin. Wschr. 39, 243 (1961).Google Scholar
  874. 873.
    Wrenshall, G. A., S. B. Andrus, and J. Mayer: High levels of pancreatic insulin coexistent with hyperplasia and degranulation of beta cells in mice with the hereditary obese-hyperglycemic syndrome. Endocrinology 56, 335 (1955).PubMedGoogle Scholar
  875. 874.
    Wünsch, E.: Zur Synthese des Glucagons. VI. Darstellung der Sequenz 20–23. Chem. Ber. 98, 797 (1965).Google Scholar
  876. 875.
    —, F. Drees: Zur Synthese des Glucagons. X. Darstellung der Sequenz 22–29. Chem. Ber. 99, 110 (1966).PubMedGoogle Scholar
  877. 876.
    — —u. J. Jentsch: Zur Synthese des Glucagons. VII.D arstellung der Sequenz 24–29. Chem. Ber. 98, 803 (1965).Google Scholar
  878. 877.
    —, u. G. Wendlberger: Zur Synthese des Glucagons. II. Darstellung der Sequenz 5 bis 8. Chem. Ber. 97, 2504 (1964).Google Scholar
  879. 878.
    — —u. J. Jentsch: Zur Synthese des Glucagons. III. Darstellung der Sequenz 9 bis 11. Chem. Ber. 97, 3298 (1964).Google Scholar
  880. 879.
    —, u. A. Zwick: Zur Synthese des Glucagons. I. Darstellung der Sequenz 1–4. Chem. Ber. 97, 2497 (1964).Google Scholar
  881. 880.
    — —Zur Synthese des Glucagons. IV. Darstellung der Sequenz 12–15. Chem. Ber. 97, 3305 (1964).Google Scholar
  882. 881.
    — —Zur Synthese des Glucagons. V. Darstellung der Sequenz 16–19. Chem. Ber. 97, 3312 (1964).Google Scholar
  883. 882.
    — —Zur Synthese des Glucagons. VIII. Darstellung der Sequenz 1–8. Chem. Ber. 99, 101 (1966).PubMedGoogle Scholar
  884. 883.
    — —Zur Synthese des Glucagons. IX. Darstellung der Sequenz 9–15. Chem. Ber. 99, 105 (1966).PubMedGoogle Scholar
  885. 884.
    — — G. Wendlberger, F. Drees, J. Jentsch u. A. Volk: Beiträge zur Synthese des Glucagons. Acta chim. Acad. Sci. hung. 44, 173 (1965).Google Scholar
  886. 885.
    Yoko, S.: Glucagon and the endocrine secretion of the pancreas. Folia endocr. jap. 38, 572 (1962).Google Scholar
  887. 886.
    Yoshinaga, T., G. Okuno, Y. Shinji, T. Tsujii, and M. Nishikawa: Pancreatic A-cell tumor associated with severe diabetes mellitus. Diabetes 15, 709 (1966).PubMedGoogle Scholar
  888. 887.
    Young, F. G.: Pancreatic hormones; insulin. In: U. S. v. Euler and H. Heller (eds.), Comparative endocrinology, vol. 1, p. 371. New York: Academic Press 1963.Google Scholar
  889. 888.
    Young, J. D., and D. Biddlecombe: The effect of human growth hormone on a glucagon-basic protein complex in serum. Aust. J. Sci. 28, 465 (1966).Google Scholar
  890. 889.
    Young, J. W., E. Shrago, and H. A. Lardy: Metabolic control of enzymes involved in lipogenesis and gluconeogenesis. Biochemistry 3, 1687 (1964).PubMedGoogle Scholar
  891. 890.
    Yudaev, N. A., and H. Li: Effect of ACTH hormone on phosphorylase activity in adrenal cortex. Fed. Proc. 23, T 1269 (1964).Google Scholar
  892. 891.
    Zain-ul-Abedin, M., and M.H. Qazi: Blood sugar levels of some reptiles found in Pakistan. Canad. J. Biochem. 43, 831 (1965).Google Scholar
  893. 892.
    Zleludkova, Z. P.: Active and inactive phosphorylase in chick embryo liver and the effect of cortisone. Zh. Evolyutsionnoi Biokhim. i. Fiziol. 2, 193 (1966). — Chem. Abstr. 65, 12503 (1966).Google Scholar
  894. 893.
    Zollinger, R. M.: Observations on the relationship of the pancreas to peptic ulcer. Bull. N.Y. Acad. Med. 39, 617 (1963).PubMedGoogle Scholar
  895. 894.
    Ulcerogenic tumor of the pancreas. J. amer. med. Ass. 190, 181 (1964).Google Scholar
  896. 895.
    Zukoski, C. F.: Mechanism of action of insulin hypoglycemia on adrenal cortical secretion. Endocrinology 78, 1264 (1966).PubMedGoogle Scholar
  897. 896.
    Zwarenstein, H., and V. v. d. Schyff: Inhibition of phosphoglucomutase by citrate. Biochem. biophys. Res. Commun. 26, 372 (1967).PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1968

Authors and Affiliations

  • Piero P. Foà
    • 1
  1. 1.Division of Research of Sinai Hospital and Department of Physiology and PharmacologyWayne State University, School of MedicineDetroit

Personalised recommendations